☰

Guido Reifenberger, M.D. - Publications

Affiliations: 
Department of Neuropathology Heinrich Heine University Düsseldorf, Düsseldorf, Nordrhein-Westfalen, Germany 
Tree Info Grants Similar researchers PubMed Report error

300 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Malta TM, Sabedot TS, Morosini NS, Datta I, Garofano L, Vallentgoed WR, Varn FS, Aldape K, D'Angelo F, Bakas S, Barnholtz-Sloan JS, Gan HK, Hasanain M, Hau AC, Johnson KC, ... ... Reifenberger G, et al. The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen. Cancer Research. PMID 38117484 DOI: 10.1158/0008-5472.CAN-23-2093  0.339
2022 Blümel L, Qin N, Berlandi J, Paisana E, Cascão R, Custódia C, Pauck D, Picard D, Langini M, Stühler K, Meyer FD, Göbbels S, Malzkorn B, Liebau MC, Barata JT, ... ... Reifenberger G, et al. Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors. Cell Death & Disease. 13: 806. PMID 36127323 DOI: 10.1038/s41419-022-05243-4  0.311
2021 Dahlrot RH, Bangsø JA, Petersen JK, Rosager AM, Sørensen MD, Reifenberger G, Hansen S, Kristensen BW. Prognostic role of Ki-67 in glioblastomas excluding contribution from non-neoplastic cells. Scientific Reports. 11: 17918. PMID 34504133 DOI: 10.1038/s41598-021-95958-9  0.318
2021 Sievers P, Henneken SC, Blume C, Sill M, Schrimpf D, Stichel D, Okonechnikov K, Reuss DE, Benzel J, Maaß KK, Kool M, Sturm D, Zheng T, Ghasemi DR, Kohlhof-Meinecke P, ... ... Reifenberger G, et al. Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors. Acta Neuropathologica. PMID 34355256 DOI: 10.1007/s00401-021-02356-6  0.331
2020 Sievers P, Sill M, Blume C, Tauziede-Espariat A, Schrimpf D, Stichel D, Reuss DE, Dogan H, Hartmann C, Mawrin C, Hasselblatt M, Stummer W, Schick U, Hench J, Frank S, ... ... Reifenberger G, et al. Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1. Acta Neuropathologica. PMID 33319313 DOI: 10.1007/s00401-020-02247-2  0.328
2020 Berger K, Turowski B, Felsberg J, Malzkorn B, Reifenberger G, Steiger HJ, Budach W, Haussmann J, Knipps J, Rapp M, Hänggi D, Sabel M, Mijderwijk HJ, Kamp MA. Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomide. Journal of Cancer Research and Clinical Oncology. PMID 32748120 DOI: 10.1007/S00432-020-03334-3  0.314
2020 Petersen JK, Boldt HB, Sørensen MD, Blach S, Dahlrot RH, Hansen S, Burton M, Thomassen M, Kruse T, Poulsen FR, Andreasen L, Hager H, Ulhøi BP, Lukacova S, Reifenberger G, et al. Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics. Neuropathology and Applied Neurobiology. PMID 32696543 DOI: 10.1111/Nan.12645  0.311
2020 Louis DN, Wesseling P, Aldape K, Brat DJ, Capper D, Cree IA, Eberhart C, Figarella-Branger D, Fouladi M, Fuller GN, Giannini C, Haberler C, Hawkins C, Komori T, Kros JM, ... ... Reifenberger G, et al. cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. Brain Pathology (Zurich, Switzerland). PMID 32307792 DOI: 10.1111/Bpa.12832  0.377
2020 Herrera-Rios D, Mughal SS, Teuber-Hanselmann S, Pierscianek D, Sucker A, Jansen P, Schimming T, Klode J, Reifenberger J, Felsberg J, Keyvani K, Brors B, Sure U, Reifenberger G, Schadendorf D, et al. Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain. Frontiers in Immunology. 11: 120. PMID 32117271 DOI: 10.3389/Fimmu.2020.00120  0.322
2019 Barthel FP, Johnson KC, Varn FS, Moskalik AD, Tanner G, Kocakavuk E, Anderson KJ, Abiola O, Aldape K, Alfaro KD, Alpar D, Amin SB, Ashley DM, Bandopadhayay P, Barnholtz-Sloan JS, ... ... Reifenberger G, et al. Longitudinal molecular trajectories of diffuse glioma in adults. Nature. PMID 31748746 DOI: 10.1038/S41586-019-1775-1  0.394
2019 Thomas C, Wefers A, Bens S, Nemes K, Agaimy A, Oyen F, Vogelgesang S, Rodriguez FJ, Brett FM, McLendon R, Bodi I, Burel-Vandenbos F, Keyvani K, Tippelt S, Poulsen FR, ... ... Reifenberger G, et al. Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults. Acta Neuropathologica. PMID 31732806 DOI: 10.1007/S00401-019-02094-W  0.446
2019 Reinhardt A, Stichel D, Schrimpf D, Koelsche C, Wefers AK, Ebrahimi A, Sievers P, Huang K, Casalini MB, Fernández-Klett F, Suwala A, Weller M, Gramatzki D, Felsberg J, Reifenberger G, et al. Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities. Acta Neuropathologica Communications. 7: 163. PMID 31661039 DOI: 10.1186/S40478-019-0801-8  0.424
2019 Von Achenbach C, Weller M, Kaulich K, Gramatzki D, Zacher A, Fabbro D, Reifenberger G, Szabó E. Synergistic growth inhibition mediated by dual PI3K/mTOR pathway targeting and genetic or direct pharmacological AKT inhibition in human glioblastoma models. Journal of Neurochemistry. PMID 31618458 DOI: 10.1111/Jnc.14899  0.304
2019 Le Rhun E, Preusser M, Roth P, Reardon DA, van den Bent M, Wen P, Reifenberger G, Weller M. Molecular targeted therapy of glioblastoma. Cancer Treatment Reviews. 80: 101896. PMID 31541850 DOI: 10.1016/J.Ctrv.2019.101896  0.412
2019 Brand F, Förster A, Christians A, Bucher M, Thomé CM, Raab MS, Westphal M, Pietsch T, von Deimling A, Reifenberger G, Claus P, Hentschel B, Weller M, Weber RG. FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomas. Acta Neuropathologica. PMID 31473790 DOI: 10.1007/S00401-019-02067-Z  0.388
2019 Varon M, Levy T, Mazor G, Ben David H, Marciano R, Kerlin Y, Prasad M, Elkabets M, Pauck D, Ahmadov U, Picard D, Qin N, Borkhardt A, Reifenberger G, Leprivier G, et al. The long non-coding RNA TP73-AS1 promotes tumorigenicity of medulloblastoma cells. International Journal of Cancer. PMID 31081944 DOI: 10.1002/Ijc.32400  0.412
2019 Wirthschaft P, Bode J, Soni H, Dietrich F, Krüwel T, Fischer B, Knobbe-Thomsen CB, Rossetti G, Hentschel A, Mack N, Schönig K, Breckwoldt MO, Schmandke A, Pusch S, Medenbach J, ... ... Reifenberger G, et al. RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomas. Acta Neuropathologica. PMID 31062076 DOI: 10.1007/S00401-019-02021-Z  0.357
2019 Louis DN, Ellison DW, Brat DJ, Aldape K, Capper D, Hawkins C, Paulus W, Perry A, Reifenberger G, Figarella-Branger D, von Deimling A, Wesseling P. cIMPACT-NOW: A practical summary of diagnostic points from Round 1 updates. Brain Pathology (Zurich, Switzerland). PMID 31038238 DOI: 10.1111/Bpa.12732  0.364
2019 Körber V, Yang J, Barah P, Wu Y, Stichel D, Gu Z, Fletcher MNC, Jones D, Hentschel B, Lamszus K, Tonn JC, Schackert G, Sabel M, Felsberg J, Zacher A, ... ... Reifenberger G, et al. Evolutionary Trajectories of IDH Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial Diagnosis. Cancer Cell. PMID 30905762 DOI: 10.1016/J.Ccell.2019.02.007  0.422
2019 Mazor G, Levin L, Picard D, Ahmadov U, Carén H, Borkhardt A, Reifenberger G, Leprivier G, Remke M, Rotblat B. The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells. Cell Death & Disease. 10: 246. PMID 30867410 DOI: 10.1038/S41419-019-1477-5  0.4
2019 Hou Y, Pinheiro J, Sahm F, Reuss DE, Schrimpf D, Stichel D, Casalini B, Koelsche C, Sievers P, Wefers AK, Reinhardt A, Ebrahimi A, Fernández-Klett F, Pusch S, Meier J, ... ... Reifenberger G, et al. Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA. Acta Neuropathologica. PMID 30759284 DOI: 10.1007/S00401-019-01969-2  0.411
2019 Krais AM, Park YJ, Reifenberger G, Meister M, Plass C, Schmeiser HH. Sensitive detection of hydroxymethylcytosine levels in normal and neoplastic cells and tissues. Electrophoresis. PMID 30724377 DOI: 10.1002/Elps.201800523  0.309
2019 Gobin M, Nazarov PV, Warta R, Timmer M, Reifenberger G, Felsberg J, Vallar L, Chalmers AJ, Herold-Mende CC, Goldbrunner R, Niclou SP, Van Dyck E. A DNA repair and cell cycle gene expression signature in primary and recurrent glioblastoma: prognostic value and clinical implications. Cancer Research. PMID 30674534 DOI: 10.1158/0008-5472.Can-18-2076  0.405
2019 Weller M, Reifenberger G, Rhun EL, Clarke JL, Soffietti R, Wick A, Chinot OL, Ducray F, Hau P, McDonald KL, Marosi C, Schnell O, Hottinger AF, Reijneveld JC, Lombardi G, et al. Molecular genetic, host-derived and clinical determinants of long-term survival in glioblastoma: First results from the ETERNITY study (EORTC 1419). Journal of Clinical Oncology. 37: 2056-2056. DOI: 10.1200/Jco.2019.37.15_Suppl.2056  0.348
2019 Wick W, Kessler T, Platten M, Meisner C, Bamberg M, Herrlinger U, Happold C, Weisang S, Boelting H, Steinbach J, Reifenberger G, Sahm F, von Deimling A, Wick A, Weller M. Impact of predictive impact of MGMT promoter methylation in malignant astrocytomas depends on the methylation subgroup. Journal of Clinical Oncology. 37: 2013-2013. DOI: 10.1200/Jco.2019.37.15_Suppl.2013  0.351
2019 Petersen JK, Boldt HB, Sorensen M, Dahlrot RH, Hansen S, Burton M, Thomassen M, Kruse T, Poulsen FR, Andreasen L, Hager H, Ulhøi BP, Lukacova S, Reifenberger G, Kristensen B. GENE-33. INTEGRATED GLIOMA DIAGNOSTICS USING TARGETED NEXT-GENERATION SEQUENCING Neuro-Oncology. 21: vi104-vi104. DOI: 10.1093/Neuonc/Noz175.435  0.391
2019 Bauer EK, Stoffels G, Blau T, Reifenberger G, Werner JM, Lohmann P, Rapp M, Fink GR, Langen K, Galldiks N. P14.29 Prediction of overall survival in patients with malignant glioma using dynamic O-(2-[18F]-fluoroethyl)-L-tyrosine PET Neuro-Oncology. 21: iii73-iii73. DOI: 10.1093/Neuonc/Noz126.264  0.351
2019 Bartl J, Forget A, Zanini M, Picard D, Qin N, Borkhardt A, Reifenberger G, Ayrault O, Remke M. Sig-03. Hhip-As1 Promotes Tumor Survival Through Stabilizing Dynein Complex 1 In Hedgehog Driven Human Brain Tumors Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz036.207  0.389
2019 Blümel L, Kerl K, Qin N, Berlandi J, Thiel K, Tegeder I, Jeibmann A, Paisana E, Custódia C, Picard D, Langini M, Stühler K, Meyer F, Malzkorn B, Liebau MC, ... ... Reifenberger G, et al. Atrt-07. Targeting Primary Ciliogenesis In Atypical Teratoid/Rhabdoid Tumors Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz036.006  0.363
2018 An Z, Knobbe-Thomsen CB, Wan X, Fan QW, Reifenberger G, Weiss WA. EGFR cooperates with EGFRvIII to recruit macrophages in glioblastoma. Cancer Research. PMID 30401716 DOI: 10.1158/0008-5472.Can-17-3551  0.348
2018 Forget A, Martignetti L, Puget S, Calzone L, Brabetz S, Picard D, Montagud A, Liva S, Sta A, Dingli F, Arras G, Rivera J, Loew D, Besnard A, Lacombe J, ... ... Reifenberger G, et al. Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling. Cancer Cell. 34: 379-395.e7. PMID 30205043 DOI: 10.1016/J.Ccell.2018.08.002  0.306
2018 Witt H, Gramatzki D, Hentschel B, Pajtler KW, Felsberg J, Schackert G, Löffler M, Capper D, Sahm F, Sill M, von Deimling A, Kool M, Herrlinger U, Westphal M, Pietsch T, ... Reifenberger G, et al. DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment. Neuro-Oncology. PMID 30053291 DOI: 10.1093/Neuonc/Noy118  0.355
2018 Zhang L, Sorensen M, Kristensen BW, Reifenberger G, McIntyre TM, Lin F. The oncometabolite D-2-hydroxyglutarate is an intercellular mediator in IDH-mutant gliomas that inhibits both complement and T cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30006485 DOI: 10.1158/1078-0432.Ccr-17-3855  0.373
2018 Suwala AK, Koch K, Rios DH, Aretz P, Uhlmann C, Ogorek I, Felsberg J, Reifenberger G, Köhrer K, Deenen R, Steiger HJ, Kahlert UD, Maciaczyk J. Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma . Oncotarget. 9: 22703-22716. PMID 29854309 DOI: 10.18632/Oncotarget.25210  0.321
2018 Capper D, Engel NW, Stichel D, Lechner M, Glöss S, Schmid S, Koelsche C, Schrimpf D, Niesen J, Wefers AK, Jones DTW, Sill M, Weigert O, Ligon KL, Olar A, ... ... Reifenberger G, et al. DNA methylation-based reclassification of olfactory neuroblastoma. Acta Neuropathologica. PMID 29730775 DOI: 10.1007/S00401-018-1854-7  0.369
2018 Ballmann C, Thiel A, Korah HE, Reis AC, Saeger W, Stepanow S, Köhrer K, Reifenberger G, Knobbe-Thomsen CB, Knappe UJ, Scholl UI. Mutations in Pituitary Cushing Adenomas-Targeted Analysis by Next-Generation Sequencing. Journal of the Endocrine Society. 2: 266-278. PMID 29600293 DOI: 10.1210/Js.2017-00364  0.382
2018 Wirthschaft P, Bode J, Simon AEM, Hoffmann E, van Laack R, Krüwel T, Dietrich F, Bucher D, Hahn A, Sahm F, Breckwoldt MO, Kurz FT, Hielscher T, Fischer B, Dross N, ... ... Reifenberger G, et al. A PRDX1-p38α heterodimer amplifies MET-driven invasion of IDH-wildtype and IDH-mutant gliomas. International Journal of Cancer. PMID 29582423 DOI: 10.1002/Ijc.31404  0.421
2018 Reinhardt A, Stichel D, Schrimpf D, Sahm F, Korshunov A, Reuss DE, Koelsche C, Huang K, Wefers AK, Hovestadt V, Sill M, Gramatzki D, Felsberg J, Reifenberger G, Koch A, et al. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. Acta Neuropathologica. PMID 29564591 DOI: 10.1007/S00401-018-1837-8  0.434
2018 Happold C, Stojcheva N, Silginer M, Weiss T, Roth P, Reifenberger G, Weller M. Transcriptional control of O-methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma. Journal of Neurochemistry. PMID 29480969 DOI: 10.1111/Jnc.14326  0.348
2018 Aldape K, Amin SB, Ashley DM, Barnholtz-Sloan JS, Bates AJ, Beroukhim R, Bock C, Brat DJ, Claus EB, Costello JF, de Groot JF, Finocchiaro G, French PJ, Gan HK, Griffith B, ... ... Reifenberger G, et al. Glioma Through the Looking GLASS: Molecular Evolution of Diffuse Gliomas and the Glioma Longitudinal AnalySiS Consortium. Neuro-Oncology. PMID 29432615 DOI: 10.1093/Neuonc/Noy020  0.372
2018 Hirsch B, Endris V, Lassmann S, Weichert W, Pfarr N, Schirmacher P, Kovaleva V, Werner M, Bonzheim I, Fend F, Sperveslage J, Kaulich K, Zacher A, Reifenberger G, Köhrer K, et al. Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics. Virchows Archiv : An International Journal of Pathology. PMID 29374318 DOI: 10.1007/S00428-017-2288-7  0.311
2018 Johann PD, Bens S, Oyen F, Wagener R, Giannini C, Perry A, Raisanen JM, Reis GF, Nobusawa S, Arita K, Felsberg J, Reifenberger G, Agaimy A, Buslei R, Capper D, et al. Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup. The American Journal of Surgical Pathology. PMID 29324471 DOI: 10.1097/Pas.0000000000001023  0.42
2018 Weller M, Papachristodoulou A, Hentschel B, Gramatzki D, Felsberg J, Loeffler M, Schackert G, Westphal M, Tonn J, Silginer M, Deimling Av, Pietsch T, Reifenberger G, Roth P. Differential elevation of TERT activity and sensitivity to temozolomide by type of TERT mutation in MGMT promoter-methylated glioblastoma. Journal of Clinical Oncology. 36: 2013-2013. DOI: 10.1200/Jco.2018.36.15_Suppl.2013  0.351
2018 Zuckermann M, Ismer B, Hovestadt V, Knobbe-Thomsen CB, Zapatka M, Northcott PA, Roussel MF, Reifenberger G, Lichter P, Pfister SM, Kawauchi D, Gronych J, Jones DT. Abstract 5109: Somatic CRISPR/Cas9-mediated gene editing enables versatile brain tumor modeling Cancer Research. 78: 5109-5109. DOI: 10.1158/1538-7445.Am2018-5109  0.415
2018 Kiesel B, M Thomé C, Weiss T, Jakola A, Darlix A, Pellerino A, Furtner J, Kerschbaumer J, Weller M, Pilkington G, Moyal EC, Henriksson R, Watts C, Rudà R, Reifenberger G, et al. CMET-26. PERIOPERATIVE IMAGING OF BRAIN METASTASES: A EUROPEAN ASSOCIATION OF NEURO-ONCOLOGY (EANO) YOUNGSTERS SURVEY Neuro-Oncology. 20: vi59-vi59. DOI: 10.1093/Neuonc/Noy148.238  0.309
2018 Silginer M, Papachristodolou A, Hentschel B, Gramatzki D, Felsberg J, Löffler M, Schackert G, Westphal M, Tonn J, Deimling Av, Pietsch T, Reifenberger G, Roth P, Weller M. Csig-27. Differential Elevation Of Tert Activity And Sensitivity To Temozolomide By Type Of Tert Mutation In Mgmt Promoter-Methylated Glioblastoma Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.193  0.303
2018 Blümel L, Kerl K, Qin N, Berlandi J, Thiel K, Tegeder I, Jeibmann A, Picard D, Langini M, Stühler K, Meyer F, Malzkorn B, Liebau MC, Johann PD, Erkek S, ... ... Reifenberger G, et al. Atrt-34. Targeting Primary Ciliogenesis In Atypical Teratoid/Rhabdoid Tumors Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.031  0.363
2017 Felsberg J, Hentschel B, Kaulich K, Gramatzki D, Zacher A, Malzkorn B, Kamp MA, Sabel MC, Simon M, Westphal M, Schackert G, Tonn JC, Pietsch T, von Deimling A, Loeffler M, ... Reifenberger G, et al. Prognostic role of Epidermal growth factor receptor variant III (EGFRvIII) positivity in EGFR-amplified primary and recurrent glioblastomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28855349 DOI: 10.1158/1078-0432.Ccr-17-0890  0.37
2017 Heß K, Purrucker J, Hegenbart U, Brokinkel B, Berndt R, Keyvani K, Monoranu CM, Löhr M, Reifenberger G, Munoz-Bendix C, Kalla J, Groß J, Schick U, Kollmer J, Klapper W, et al. Cerebral amyloidoma is characterized by B-cell clonality and a stable clinical course. Brain Pathology (Zurich, Switzerland). PMID 28160367 DOI: 10.1111/Bpa.12493  0.305
2017 Weller M, Sill M, Hentschel B, Felsberg J, Jones DTW, Gramatzki D, Kaulich K, Happold C, Tonn J, Herrlinger U, Schackert G, Westphal M, Capper D, Kumar R, Hemminki K, ... ... Reifenberger G, et al. Clinical and molecular features associated with long-term survival of elderly patients with glioblastoma. Journal of Clinical Oncology. 35: 2013-2013. DOI: 10.1200/Jco.2017.35.15_Suppl.2013  0.311
2017 Mangani D, Weller M, Sadr ES, Willscher E, Seystahl K, Reifenberger G, Tabatabai G, Binder H, Schneider H. Abstract B88: TGF-β pathway-mediated escape from VEGF blockade is linked with angiogenesis and immune-suppression in murine glioma models Cancer Immunology Research. 5. DOI: 10.1158/2326-6074.Tumimm16-B88  0.331
2017 Witt H, Gramatzki D, Hentschel B, Pajtler KW, Schackert G, Capper D, Sahm F, Deimling Av, Westphal M, Herrlinger U, Pietsch T, Löffler M, Reifenberger G, Pfister SM, Tonn J, et al. Path-24. Molecular Subgroups Of Adult Ependymal Tumors: An Analysis Of The German Glioma Network Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.714  0.341
2017 Happold C, Felsberg J, Clarke J, Soffietti R, Marosi C, Krex D, Ducray F, Hau P, Reijneveld J, Weyerbrock A, Wick A, Reardon D, Glas M, Razis E, Herrlinger U, ... ... Reifenberger G, et al. ACTR-23. MOLECULAR GENETIC, HOST-DERIVED AND CLINICAL DETERMINANTS OF LONG-TERM SURVIVAL IN GLIOBLASTOMA: FIRST RESULTS FROM THE BRAIN TUMOR FUNDERS’ COLLABORATIVE CONSORTIUM Neuro-Oncology. 19: vi5-vi6. DOI: 10.1093/Neuonc/Nox168.018  0.355
2017 Marquardt V, Pauck D, Hansen FK, Picard D, Felsberg J, Reifenberger G, Borkhardt A, Kurz T, Remke M. Trth-28. High Throughput Screening Of Novel Histone Deacetylase Inhibitors For Epigenetic Therapy Of Primary Brain Tumors. Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox083.238  0.401
2017 Mangani D, Weller M, Sadr ES, Willscher E, Seystahl K, Reifenberger G, Tabatabai G, Binder H, Schneider H. P08.36 TGF-β pathway-mediated escape from VEGF blockade is linked with angiogenesis and immune-suppression in murine glioma models. Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox036.225  0.333
2016 Schliesser MG, Claus R, Hielscher T, Grimm C, Weichenhan D, Blaes J, Wiestler B, Hau P, Schramm J, Sahm F, Weiß EK, Weiler M, Baer C, Schmidt-Graf F, Schackert G, ... ... Reifenberger G, et al. Prognostic relevance of miRNA-155 methylation in anaplastic glioma. Oncotarget. PMID 27880937 DOI: 10.18632/Oncotarget.13452  0.335
2016 Bender S, Gronych J, Warnatz H, Hutter B, Gröbner S, Ryzhova M, Pfaff E, Hovestadt V, Weinberg F, Halbach S, Kool M, Northcott PA, Sturm D, Bjerke L, Zichner T, ... ... Reifenberger G, et al. Recurrent MET fusion genes represent a drug target in pediatric glioblastoma Nature Medicine. 22: 1314-1320. PMID 27748748 DOI: 10.1038/Nm.4204  0.366
2016 Malzkorn B, Reifenberger G. Practical implications of integrated glioma classification according to the World Health Organization classification of tumors of the central nervous system 2016. Current Opinion in Oncology. PMID 27606698 DOI: 10.1097/Cco.0000000000000327  0.377
2016 Depner C, Zum Buttel H, Böğürcü N, Cuesta AM, Aburto MR, Seidel S, Finkelmeier F, Foss F, Hofmann J, Kaulich K, Barbus S, Segarra M, Reifenberger G, Garvalov BK, Acker T, et al. EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance. Nature Communications. 7: 12329. PMID 27470974 DOI: 10.1038/Ncomms12329  0.326
2016 Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathologica. 131: 803-20. PMID 27157931 DOI: 10.1007/S00401-016-1545-1  0.433
2016 Gramatzki D, Roth P, Felsberg J, Hofer S, Rushing EJ, Hentschel B, Westphal M, Krex D, Simon M, Schnell O, Wick W, Reifenberger G, Weller M. Chemotherapy for intracranial ependymoma in adults. Bmc Cancer. 16: 287. PMID 27108407 DOI: 10.1186/S12885-016-2323-0  0.349
2016 Masui K, Mischel PS, Reifenberger G. Molecular classification of gliomas. Handbook of Clinical Neurology. 134: 97-120. PMID 26948350 DOI: 10.1016/B978-0-12-802997-8.00006-2  0.41
2016 Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DT, Capper D, Sill M, Buchhalter I, Northcott PA, Leis I, Ryzhova M, Koelsche C, Pfaff E, Allen SJ, Balasubramanian G, ... ... Reifenberger G, et al. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell. 164: 1060-1072. PMID 26919435 DOI: 10.1016/J.Cell.2016.01.015  0.42
2016 Zacher A, Kaulich K, Stepanow S, Wolter M, Köhrer K, Felsberg J, Malzkorn B, Reifenberger G. Molecular diagnostics of gliomas using next generation sequencing of a glioma-tailored gene panel. Brain Pathology (Zurich, Switzerland). PMID 26919320 DOI: 10.1111/Bpa.12367  0.426
2016 Stojcheva N, Schechtmann G, Sass S, Roth P, Florea AM, Stefanski A, Stühler K, Wolter M, Müller NS, Theis FJ, Weller M, Reifenberger G, Happold C. MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM. Oncotarget. PMID 26887050 DOI: 10.18632/Oncotarget.7346  0.311
2016 Suchorska B, Weller M, Tabatabai G, Senft C, Hau P, Sabel MC, Herrlinger U, Ketter R, Schlegel U, Marosi C, Reifenberger G, Wick W, Tonn JC, Wirsching HG. Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial. Neuro-Oncology. PMID 26823503 DOI: 10.1227/01.Neu.0000467098.06935.3D  0.339
2016 Codó P, Weller M, Kaulich K, Schraivogel D, Silginer M, Reifenberger G, Meister G, Roth P. Control of glioma cell migration and invasiveness by GDF-15. Oncotarget. PMID 26741507 DOI: 10.18632/Oncotarget.6816  0.339
2016 Weller M, Hentschel B, Kaulich K, Kamp M, Felsberg J, Sabel M, Simon M, Westphal M, Schackert G, Tonn J, Gramatzki D, Pietsch T, Deimling Av, Loeffler M, Reifenberger G. EGFR gene amplification and variant III (EGFRvIII) mutation in primary and recurrent glioblastoma. Journal of Clinical Oncology. 34: 2042-2042. DOI: 10.1200/Jco.2016.34.15_Suppl.2042  0.405
2016 Zuckermann M, Hovestadt V, Knobbe-Thomsen CB, Zapatka M, Northcott PA, Schramm K, Belic J, Jones DT, Tschida B, Moriarity B, Largaespada D, Roussel MF, Korshunov A, Reifenberger G, Pfister SM, et al. PCM-15SOMATIC CRISPR/Cas9-MEDIATED TUMOR SUPPRESSOR DISRUPTION ENABLES VERSATILE BRAIN TUMOR MODELING Neuro-Oncology. 18: iii142.2-iii142. DOI: 10.1093/Neuonc/Now080.15  0.386
2016 Kratz A, Sahm F, Schrimpf D, Jones DT, Reuß D, Kölsche C, Huang K, Wefers AK, Hovestadt V, Gramatzki D, Felsberg J, Koch A, Thomale UW, Reifenberger G, Becker A, et al. HG-68COMBINED ALTERATIONS IN MAPK PATHWAY GENES, CDKN2A/B AND ATRX CHARACTERIZE ANAPLASTIC PILOCYTIC ASTROCYTOMA Neuro-Oncology. 18: iii63.2-iii63. DOI: 10.1093/Neuonc/Now073.64  0.387
2015 Herrlinger U, Jones DT, Glas M, Hattingen E, Gramatzki D, Stuplich M, Felsberg J, Bähr O, Gielen GH, Simon M, Wiewrodt D, Schabet M, Hovestadt V, Capper D, Steinbach JP, ... ... Reifenberger G, et al. Gliomatosis cerebri: no evidence for a separate brain tumor entity. Acta Neuropathologica. PMID 26493382 DOI: 10.1007/s00401-015-1495-z  0.348
2015 Korshunov A, Capper D, Reuss D, Schrimpf D, Ryzhova M, Hovestadt V, Sturm D, Meyer J, Jones C, Zheludkova O, Kumirova E, Golanov A, Kool M, Schüller U, Mittelbronn M, ... ... Reifenberger G, et al. Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity. Acta Neuropathologica. PMID 26482474 DOI: 10.1007/S00401-015-1493-1  0.417
2015 Reuss DE, Kratz A, Sahm F, Capper D, Schrimpf D, Koelsche C, Hovestadt V, Bewerunge-Hudler M, Jones DT, Schittenhelm J, Mittelbronn M, Rushing E, Simon M, Westphal M, Unterberg A, ... ... Reifenberger G, et al. Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities. Acta Neuropathologica. PMID 26087904 DOI: 10.1007/S00401-015-1454-8  0.313
2015 Zuckermann M, Hovestadt V, Knobbe-Thomsen CB, Zapatka M, Northcott PA, Schramm K, Belic J, Jones DT, Tschida B, Moriarity B, Largaespada D, Roussel MF, Korshunov A, Reifenberger G, Pfister SM, et al. Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling. Nature Communications. 6: 7391. PMID 26067104 DOI: 10.1038/Ncomms8391  0.331
2015 Aldape K, Zadeh G, Mansouri S, Reifenberger G, von Deimling A. Glioblastoma: pathology, molecular mechanisms and markers. Acta Neuropathologica. 129: 829-48. PMID 25943888 DOI: 10.1007/S00401-015-1432-1  0.431
2015 Weller M, Weber RG, Willscher E, Riehmer V, Hentschel B, Kreuz M, Felsberg J, Beyer U, Löffler-Wirth H, Kaulich K, Steinbach JP, Hartmann C, Gramatzki D, Schramm J, Westphal M, ... ... Reifenberger G, et al. Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups. Acta Neuropathologica. 129: 679-93. PMID 25783747 DOI: 10.1007/S00401-015-1409-0  0.411
2015 Korshunov A, Ryzhova M, Hovestadt V, Bender S, Sturm D, Capper D, Meyer J, Schrimpf D, Kool M, Northcott PA, Zheludkova O, Milde T, Witt O, Kulozik AE, Reifenberger G, et al. Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers. Acta Neuropathologica. 129: 669-78. PMID 25752754 DOI: 10.1007/S00401-015-1405-4  0.455
2015 Kamp MA, Felsberg J, Sadat H, Kuzibaev J, Steiger HJ, Rapp M, Reifenberger G, Dibué M, Sabel M. 5-ALA-induced fluorescence behavior of reactive tissue changes following glioblastoma treatment with radiation and chemotherapy. Acta Neurochirurgica. 157: 207-13; discussion 2. PMID 25547719 DOI: 10.1007/S00701-014-2313-4  0.358
2015 Suchorska B, Weller M, Tabatabai G, Senft C, Hau P, Sabel M, Herrlinger U, Ketter R, Schlegel US, Marosi C, Reifenberger G, Wick W, Tonn J, Wirsching H. Does extent of resection matter in recurrent glioblastoma? Lessons from the DIRECTOR trial. Journal of Clinical Oncology. 33: 2041-2041. DOI: 10.1200/Jco.2015.33.15_Suppl.2041  0.335
2015 Weller M, Weber R, Willscher E, Riehmer V, Hentschel B, Kreuz M, Felsberg J, Beyer U, Loeffler-Wirth H, Kaulich K, Gramatzki D, Westphal M, Schackert G, Simon M, Tonn J, ... ... Reifenberger G, et al. Molecular classification of diffuse cerebral gliomas using genome- and transcriptome-wide profiling. Journal of Clinical Oncology. 33: 2007-2007. DOI: 10.1200/Jco.2015.33.15_Suppl.2007  0.409
2015 Zuckermann M, Hovestadt V, Knobbe-Thomsen CB, Zapatka M, Northcott PA, Schramm K, Belic J, Jones DTW, Tschida B, Moriarity B, Largaespada D, Roussel MF, Korshunov A, Reifenberger G, Pfister SM, et al. Abstract PR02: Somatic CRISPR/Cas9-mediated tumor suppressor disruption enables versatile brain tumor modeling Brain. 75. DOI: 10.1158/1538-7445.Brain15-Pr02  0.413
2014 Ahmad M, Frei K, Willscher E, Stefanski A, Kaulich K, Roth P, Stühler K, Reifenberger G, Binder H, Weller M. How stemlike are sphere cultures from long-term cancer cell lines? Lessons from mouse glioma models. Journal of Neuropathology and Experimental Neurology. 73: 1062-77. PMID 25289892 DOI: 10.1097/Nen.0000000000000130  0.316
2014 Northcott PA, Lee C, Zichner T, Stütz AM, Erkek S, Kawauchi D, Shih DJ, Hovestadt V, Zapatka M, Sturm D, Jones DT, Kool M, Remke M, Cavalli FM, Zuyderduyn S, ... ... Reifenberger G, et al. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature. 511: 428-34. PMID 25043047 DOI: 10.1038/Nature13379  0.304
2014 Wiestler B, Capper D, Hovestadt V, Sill M, Jones DT, Hartmann C, Felsberg J, Platten M, Feiden W, Keyvani K, Pfister SM, Wiestler OD, Meyermann R, Reifenberger G, Pietsch T, et al. Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial. Neuro-Oncology. 16: 1630-8. PMID 25028501 DOI: 10.1093/Neuonc/Nou138  0.338
2014 Wiestler B, Capper D, Sill M, Jones DT, Hovestadt V, Sturm D, Koelsche C, Bertoni A, Schweizer L, Korshunov A, Weiß EK, Schliesser MG, Radbruch A, Herold-Mende C, Roth P, ... ... Reifenberger G, et al. Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma. Acta Neuropathologica. 128: 561-71. PMID 25008768 DOI: 10.1007/S00401-014-1315-X  0.426
2014 Wick W, Weller M, van den Bent M, Sanson M, Weiler M, von Deimling A, Plass C, Hegi M, Platten M, Reifenberger G. MGMT testing--the challenges for biomarker-based glioma treatment. Nature Reviews. Neurology. 10: 372-85. PMID 24912512 DOI: 10.1038/Nrneurol.2014.100  0.338
2014 Hovestadt V, Jones DT, Picelli S, Wang W, Kool M, Northcott PA, Sultan M, Stachurski K, Ryzhova M, Warnatz HJ, Ralser M, Brun S, Bunt J, Jäger N, Kleinheinz K, ... ... Reifenberger G, et al. Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing. Nature. 510: 537-41. PMID 24847876 DOI: 10.1038/Nature13268  0.336
2014 Pietsch T, Schmidt R, Remke M, Korshunov A, Hovestadt V, Jones DT, Felsberg J, Kaulich K, Goschzik T, Kool M, Northcott PA, von Hoff K, von Bueren AO, Friedrich C, Mynarek M, ... ... Reifenberger G, et al. Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort. Acta Neuropathologica. 128: 137-49. PMID 24791927 DOI: 10.1007/S00401-014-1276-0  0.344
2014 Riehmer V, Gietzelt J, Beyer U, Hentschel B, Westphal M, Schackert G, Sabel MC, Radlwimmer B, Pietsch T, Reifenberger G, Weller M, Weber RG, Loeffler M. Genomic profiling reveals distinctive molecular relapse patterns in IDH1/2 wild-type glioblastoma. Genes, Chromosomes & Cancer. 53: 589-605. PMID 24706357 DOI: 10.1002/Gcc.22169  0.411
2014 Kool M, Jones DT, Jäger N, Northcott PA, Pugh TJ, Hovestadt V, Piro RM, Esparza LA, Markant SL, Remke M, Milde T, Bourdeaut F, Ryzhova M, Sturm D, Pfaff E, ... ... Reifenberger G, et al. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell. 25: 393-405. PMID 24651015 DOI: 10.1016/J.Ccr.2014.02.004  0.335
2014 Reifenberger G, Weber RG, Riehmer V, Kaulich K, Willscher E, Wirth H, Gietzelt J, Hentschel B, Westphal M, Simon M, Schackert G, Schramm J, Matschke J, Sabel MC, Gramatzki D, et al. Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling. International Journal of Cancer. Journal International Du Cancer. 135: 1822-31. PMID 24615357 DOI: 10.1002/Ijc.28836  0.37
2014 Weller M, Kaulich K, Hentschel B, Felsberg J, Gramatzki D, Pietsch T, Simon M, Westphal M, Schackert G, Tonn JC, von Deimling A, Davis T, Weiss WA, Loeffler M, Reifenberger G, et al. Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy. International Journal of Cancer. Journal International Du Cancer. 134: 2437-47. PMID 24614983 DOI: 10.1002/Ijc.28576  0.369
2014 Delic S, Lottmann N, Stelzl A, Liesenberg F, Wolter M, Götze S, Zapatka M, Shiio Y, Sabel MC, Felsberg J, Reifenberger G, Riemenschneider MJ. MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation. Neuro-Oncology. 16: 179-90. PMID 24305703 DOI: 10.1093/Neuonc/Not164  0.343
2014 Wiestler B, Capper D, Hovestadt V, Sill M, Jones D, Hartmann C, Felsberg J, Platten M, Keyvani K, Pfister S, Wiestler O, Meyermann R, Reifenberger G, Pietsch T, von Deimling A, et al. Determining the glioma CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide methylation data in the biomarker cohort of the NOA-04 trial. Journal of Clinical Oncology. 32: 2017-2017. DOI: 10.1200/Jco.2014.32.15_Suppl.2017  0.37
2014 Weller M, Weber R, Riehmer V, Kaulich K, Willscher E, Wirth H, Hentschel B, Westphal M, Simon M, Schackert G, Sabel M, Gramatzki D, Felsberg J, Steinbach JP, Pietsch T, ... ... Reifenberger G, et al. Do host factors determine long-term survival in glioblastoma? A genome/transcriptome profiling study by the German Glioma Network. Journal of Clinical Oncology. 32: 2014-2014. DOI: 10.1200/Jco.2014.32.15_Suppl.2014  0.308
2014 Wirsching H, Krishnan S, Florea A, Frei K, Krayenbühl N, Hasenbach K, Reifenberger G, Weller M, Tabatabai G. Abstract 203: Inhibiting invasion and stemness in glioblastoma by thymosin beta 4 gene silencing: a new therapeutic target Cancer Research. 74: 203-203. DOI: 10.1158/1538-7445.Am2014-203  0.36
2014 Dunkl V, Cleff C, Stoffels G, Judov N, Sarikaya-Seiwert S, Law I, Bøgeskov L, Nysom K, Andersen SB, Steiger H, Fink GR, Reifenberger G, Shah NJ, Coenen HH, Langen K, et al. NI-19THE USE OF DYNAMIC O-(2-[18F]fluoroethyl)-L-TYROSINE-PET IN THE CLINICAL EVALUATION OF BRAIN TUMORS IN CHILDREN AND ADOLESCENTS. Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou264.18  0.384
2014 Wick W, Hentschel B, Gramatzki D, Simon M, Schackert G, Tonn J, Westphal M, Tatagiba M, Sabel M, Weyerbrock A, Pietsch T, Reifenberger G, Loeffler M, Weller M. Bi-32Risk Factor Analysis For Patients With Newly Diagnosed Glioblastoma Who Did Not Receive Salvage Therapy Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou239.32  0.323
2014 Tabatabai G, Felsberg J, Sabel M, Kaulich K, Hofer S, Westphal M, Weller M, Reifenberger G. Ai-28Recurrent Glioblastomas After Treatment With Bevacizumab. Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou238.28  0.393
2014 Reifenberger G, Malzkorn B, Acker T, Bettstetter M, Buslei R, Deimling Av, Dietmaier W, Dubbink HJ, Eigenbrod S, Garvalov BK, Gerstenmaier U, Giese A, Haase D, Hasselblatt M, Kirches E, et al. Results Of The International Interlaboratory Comparison Of Mgmt Promoter Methylation Analysis Involving Twenty-Three Academic Centers In Germany, Austria And The Netherlands Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou209.30  0.376
2014 Weller M, Weber RG, Riehmer V, Kaulich K, Willscher E, Wirth H, Gietzelt J, Hentschel B, Westphal M, Simon M, Schackert G, Schramm J, Matschke J, Sabel MC, Gramatzki D, ... ... Reifenberger G, et al. Molecular Genetic Determinants Of Long-Term Survival With Glioblastoma Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou209.19  0.406
2014 Tabatabai G, Wirsching H, Krishnan S, Florea A, Frei K, Krayenbühl N, Hasenbach K, Reifenberger G, Weller M. Inhibiting Invasion And Stemness In Glioblastoma By Thymosin Beta 4 Gene Silencing: A Potential Therapeutic Target? Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou206.79  0.352
2014 Wick W, Wiestler B, Capper D, Sill M, Hovestadt V, Schliesser MG, Weiss E, Jones DTW, Roth P, Pfister SM, Korshunov A, Platten M, Reifenberger G, von Deimling A, Weller M. PROGNOSTIC AND PREDICTIVE BIOMARKER-BASED SUBGROUPS IN THE NOA-04 TRIAL Neuro-Oncology. 16: iii4-iii4. DOI: 10.1093/Neuonc/Nou206.14  0.439
2014 Veiser A, Kaulich K, Stepanow S, Wolter M, Köhrer K, Reifenberger G. P04.21Molecular Diagnostics Of Malignant Gliomas Using Next-Generation Gene Panel Sequencing. Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou174.153  0.426
2013 Galldiks N, Stoffels G, Ruge MI, Rapp M, Sabel M, Reifenberger G, Erdem Z, Shah NJ, Fink GR, Coenen HH, Langen KJ. Role of O-(2-18F-fluoroethyl)-L-tyrosine PET as a diagnostic tool for detection of malignant progression in patients with low-grade glioma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 2046-54. PMID 24159047 DOI: 10.2967/Jnumed.113.123836  0.34
2013 Fan QW, Cheng CK, Gustafson WC, Charron E, Zipper P, Wong RA, Chen J, Lau J, Knobbe-Thomsen C, Weller M, Jura N, Reifenberger G, Shokat KM, Weiss WA. EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma. Cancer Cell. 24: 438-49. PMID 24135280 DOI: 10.1016/J.Ccr.2013.09.004  0.318
2013 Kreth FW, Thon N, Simon M, Westphal M, Schackert G, Nikkhah G, Hentschel B, Reifenberger G, Pietsch T, Weller M, Tonn JC. Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 24: 3117-23. PMID 24130262 DOI: 10.1093/Annonc/Mdt388  0.346
2013 Wick W, Meisner C, Hentschel B, Platten M, Schilling A, Wiestler B, Sabel MC, Koeppen S, Ketter R, Weiler M, Tabatabai G, von Deimling A, Gramatzki D, Westphal M, Schackert G, ... ... Reifenberger G, et al. Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation. Neurology. 81: 1515-22. PMID 24068788 DOI: 10.1212/Wnl.0B013E3182A95680  0.393
2013 Tiebel N, Lichota A, Scharbrodt W, Foerster AF, Toedt C, Reifenberger G, Malzkorn B. Intradural, extramedullary anaplastic astrocytoma arising from the first sacral nerve root. Jama Neurology. 70: 1450-1. PMID 24042468 DOI: 10.1001/2013.Jamaneurol.368  0.397
2013 Hoell JI, Gombert M, Bartenhagen C, Ginzel S, Husemann P, Felsberg J, Reifenberger G, Eggert A, Dugas M, Schönberger S, Borkhardt A, Fischer U. Whole-genome paired-end analysis confirms remarkable genomic stability of atypical teratoid/rhabdoid tumors. Genes, Chromosomes & Cancer. 52: 983-5. PMID 23929726 DOI: 10.1002/Gcc.22092  0.301
2013 Hartmann C, Hentschel B, Simon M, Westphal M, Schackert G, Tonn JC, Loeffler M, Reifenberger G, Pietsch T, von Deimling A, Weller M. Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 5146-57. PMID 23918605 DOI: 10.1158/1078-0432.Ccr-13-0017  0.377
2013 Weller M, Pfister SM, Wick W, Hegi ME, Reifenberger G, Stupp R. Molecular neuro-oncology in clinical practice: a new horizon. The Lancet. Oncology. 14: e370-9. PMID 23896276 DOI: 10.1016/S1470-2045(13)70168-2  0.36
2013 Jones DT, Hutter B, Jäger N, Korshunov A, Kool M, Warnatz HJ, Zichner T, Lambert SR, Ryzhova M, Quang DA, Fontebasso AM, Stütz AM, Hutter S, Zuckermann M, Sturm D, ... ... Reifenberger G, et al. Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nature Genetics. 45: 927-32. PMID 23817572 DOI: 10.1038/Ng.2682  0.421
2013 Tönjes M, Barbus S, Park YJ, Wang W, Schlotter M, Lindroth AM, Pleier SV, Bai AH, Karra D, Piro RM, Felsberg J, Addington A, Lemke D, Weibrecht I, Hovestadt V, ... ... Reifenberger G, et al. BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1. Nature Medicine. 19: 901-8. PMID 23793099 DOI: 10.1038/Nm.3217  0.388
2013 Hovestadt V, Remke M, Kool M, Pietsch T, Northcott PA, Fischer R, Cavalli FM, Ramaswamy V, Zapatka M, Reifenberger G, Rutkowski S, Schick M, Bewerunge-Hudler M, Korshunov A, Lichter P, et al. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays. Acta Neuropathologica. 125: 913-6. PMID 23670100 DOI: 10.1007/S00401-013-1126-5  0.343
2013 Gutenberg A, Bock HC, Brück W, Doerner L, Mehdorn HM, Roggendorf W, Westphal M, Felsberg J, Reifenberger G, Giese A. MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers. British Journal of Neurosurgery. 27: 772-8. PMID 23662801 DOI: 10.3109/02688697.2013.791664  0.359
2013 Wiestler B, Claus R, Hartlieb SA, Schliesser MG, Weiss EK, Hielscher T, Platten M, Dittmann LM, Meisner C, Felsberg J, Happold C, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, ... ... Reifenberger G, et al. Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective. Neuro-Oncology. 15: 1017-26. PMID 23595628 DOI: 10.1093/Neuonc/Not043  0.389
2013 Rapp M, Heinzel A, Galldiks N, Stoffels G, Felsberg J, Ewelt C, Sabel M, Steiger HJ, Reifenberger G, Beez T, Coenen HH, Floeth FW, Langen KJ. Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 229-35. PMID 23232275 DOI: 10.2967/Jnumed.112.109603  0.328
2013 Tabatabai G, Wick W, Reifenberger G, Steinbach JP, Schnell O, Hau P, Herrlinger U, Sabel M, Ketter R, Schlegel US, Marosi C, Goldbrunner R, Homicsko K, Nikkhah G, Pichler J, et al. Dose-intensified rechallenge with temozolomide: One week on/one week off versus 3 weeks on/one week off in patients with progressive or recurrent glioblastoma (DIRECTOR). Journal of Clinical Oncology. 31: TPS2103-TPS2103. DOI: 10.1200/Jco.2013.31.15_Suppl.Tps2103  0.337
2013 Weller M, Hentschel B, Simon M, Westphal M, Schackert G, Tonn JC, Loeffler M, Reifenberger G, Pietsch T, Deimling Av, Hartmann C. Long-term survival in primary glioblastoma revisited: The contribution of isocitrate dehydrogenase mutations. Journal of Clinical Oncology. 31: 2027-2027. DOI: 10.1200/Jco.2013.31.15_Suppl.2027  0.36
2013 Jones DT, Hutter B, Jäger N, Korshunov A, Kool M, Lambert SR, Quang DAK, Fontebasso AM, Ryzhova M, Warnatz H, Zichner T, Korbel JO, Wolf S, Yaspo M, Ligon KL, ... ... Reifenberger G, et al. Abstract 4594: Recurrent FGFR1 hotspot mutations represent a novel therapeutic target in childhood astrocytoma. Cancer Research. 73: 4594-4594. DOI: 10.1158/1538-7445.Am2013-4594  0.426
2012 Kliese N, Gobrecht P, Pachow D, Andrae N, Wilisch-Neumann A, Kirches E, Riek-Burchardt M, Angenstein F, Reifenberger G, Riemenschneider MJ, Meese E, Panayotova-Dimitrova D, Gutmann DH, Mawrin C. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells. Oncogene. 32: 4712-20. PMID 23108408 DOI: 10.1038/Onc.2012.468  0.314
2012 Weller M, Stupp R, Hegi ME, van den Bent M, Tonn JC, Sanson M, Wick W, Reifenberger G. Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice. Neuro-Oncology. 14: iv100-8. PMID 23095825 DOI: 10.1093/Neuonc/Nos206  0.422
2012 Sturm D, Witt H, Hovestadt V, Khuong-Quang DA, Jones DT, Konermann C, Pfaff E, Tönjes M, Sill M, Bender S, Kool M, Zapatka M, Becker N, Zucknick M, Hielscher T, ... ... Reifenberger G, et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell. 22: 425-37. PMID 23079654 DOI: 10.1016/J.Ccr.2012.08.024  0.36
2012 Liu XY, Gerges N, Korshunov A, Sabha N, Khuong-Quang DA, Fontebasso AM, Fleming A, Hadjadj D, Schwartzentruber J, Majewski J, Dong Z, Siegel P, Albrecht S, Croul S, Jones DT, ... ... Reifenberger G, et al. Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations. Acta Neuropathologica. 124: 615-25. PMID 22886134 DOI: 10.1007/S00401-012-1031-3  0.386
2012 Jones DT, Jäger N, Kool M, Zichner T, Hutter B, Sultan M, Cho YJ, Pugh TJ, Hovestadt V, Stütz AM, Rausch T, Warnatz HJ, Ryzhova M, Bender S, Sturm D, ... ... Reifenberger G, et al. Dissecting the genomic complexity underlying medulloblastoma. Nature. 488: 100-5. PMID 22832583 DOI: 10.1038/Nature11284  0.385
2012 von dem Knesebeck A, Felsberg J, Waha A, Hartmann W, Scheffler B, Glas M, Hammes J, Mikeska T, Yan PS, Endl E, Simon M, Reifenberger G, Pietsch T, Waha A. RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomas. Neoplasia (New York, N.Y.). 14: 526-34. PMID 22787434 DOI: 10.1596/Neo.12360  0.384
2012 Sasaki M, Knobbe CB, Munger JC, Lind EF, Brenner D, Brüstle A, Harris IS, Holmes R, Wakeham A, Haight J, You-Ten A, Li WY, Schalm S, Su SM, Virtanen C, ... Reifenberger G, et al. IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics. Nature. 488: 656-9. PMID 22763442 DOI: 10.1038/Nature11323  0.323
2012 Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, Sabel M, Combs SE, Vesper J, Braun C, Meixensberger J, Ketter R, ... ... Reifenberger G, et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. The Lancet. Oncology. 13: 707-15. PMID 22578793 DOI: 10.1016/S1470-2045(12)70164-X  0.316
2012 Happold C, Roth P, Wick W, Schmidt N, Florea AM, Silginer M, Reifenberger G, Weller M. Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells. Journal of Neurochemistry. 122: 444-55. PMID 22564186 DOI: 10.1111/J.1471-4159.2012.07781.X  0.327
2012 Stummer W, Meinel T, Ewelt C, Martus P, Jakobs O, Felsberg J, Reifenberger G. Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery. Journal of Neuro-Oncology. 108: 89-97. PMID 22307805 DOI: 10.1007/S11060-012-0798-3  0.394
2012 Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DA, Tönjes M, Hovestadt V, Albrecht S, Kool M, Nantel A, Konermann C, ... ... Reifenberger G, et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature. 482: 226-31. PMID 22286061 DOI: 10.1038/Nature10833  0.336
2012 Dittmann LM, Danner A, Gronych J, Wolter M, Stühler K, Grzendowski M, Becker N, Bageritz J, Goidts V, Toedt G, Felsberg J, Sabel MC, Barbus S, Reifenberger G, Lichter P, et al. Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitro. Oncogene. 31: 3409-18. PMID 22158042 DOI: 10.1038/Onc.2011.513  0.39
2012 Augustin I, Goidts V, Bongers A, Kerr G, Vollert G, Radlwimmer B, Hartmann C, Herold-Mende C, Reifenberger G, von Deimling A, Boutros M. The Wnt secretion protein Evi/Gpr177 promotes glioma tumourigenesis. Embo Molecular Medicine. 4: 38-51. PMID 22147553 DOI: 10.1002/Emmm.201100186  0.34
2012 Reifenberger G, Hentschel B, Felsberg J, Schackert G, Simon M, Schnell O, Westphal M, Wick W, Pietsch T, Loeffler M, Weller M. Predictive impact of MGMT promoter methylation in glioblastoma of the elderly. International Journal of Cancer. Journal International Du Cancer. 131: 1342-50. PMID 22139906 DOI: 10.1002/Ijc.27385  0.333
2012 Kamp MA, Grosser P, Felsberg J, Slotty PJ, Steiger HJ, Reifenberger G, Sabel M. 5-aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study. Acta Neurochirurgica. 154: 223-8; discussion 22. PMID 22080159 DOI: 10.1007/S00701-011-1200-5  0.322
2012 Goidts V, Bageritz J, Puccio L, Nakata S, Zapatka M, Barbus S, Toedt G, Campos B, Korshunov A, Momma S, Schaftingen EV, Reifenberger G, Herold-Mende C, Lichter P, Radlwimmer B. RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival Oncogene. 31: 3235-3243. PMID 22056879 DOI: 10.1038/Onc.2011.490  0.427
2012 Delic S, Lottmann N, Jetschke K, Reifenberger G, Riemenschneider MJ. Identification and functional validation of CDH11, PCSK6 and SH3GL3 as novel glioma invasion‐associated candidate genes Neuropathology and Applied Neurobiology. 38: 201-212. PMID 21722156 DOI: 10.1111/J.1365-2990.2011.01207.X  0.352
2012 Schmidt N, Windmann S, Reifenberger G, Riemenschneider MJ. DNA hypermethylation and histone modifications downregulate the candidate tumor suppressor gene RRP22 on 22q12 in human gliomas. Brain Pathology (Zurich, Switzerland). 22: 17-25. PMID 21631628 DOI: 10.1111/J.1750-3639.2011.00507.X  0.404
2012 Tabatabai G, Felsberg J, Sabel M, Hofer S, Westphal M, Weller M, Reifenberger G. Bevacizumab failure in glioblastomas. Journal of Clinical Oncology. 30: 2067-2067. DOI: 10.1200/Jco.2012.30.15_Suppl.2067  0.382
2012 Wick W, Meisner C, Platten M, Simon M, Nikkhah G, Papsdorf K, Sabel M, Braun C, Reifenberger G, Weller M. MGMT promoter methylation as a predictive biomarker for response to radiotherapy versus chemotherapy in malignant astrocytomas in the elderly: The NOA-08 trial. Journal of Clinical Oncology. 30: 2000-2000. DOI: 10.1200/Jco.2012.30.15_Suppl.2000  0.361
2012 Sturm D, Witt H, Jacob K, Konermann C, Jones DT, Pfaff E, Korshunov A, Rizhova M, Hovestadt V, Remke M, Meter Tv, Frühwald M, Kramm C, Kulozik AE, Deimling Av, ... ... Reifenberger G, et al. Abstract 3687: An integrative genomics approach identifies distinct molecular and epigenetic subgroups of pediatric glioblastoma Cancer Research. 72: 3687-3687. DOI: 10.1158/1538-7445.Am2012-3687  0.421
2012 Leonard A, Wolff J, Sengupta R, Marassa J, Piwnica-Worms D, Rubin J, Pollack I, Jakacki R, Butterfield L, Okada H, Fangusaro J, Warren KE, Mullins C, Jurgen P, Julia S, ... ... Reifenberger G, et al. HIGH GRADE GLIOMAS Neuro-Oncology. 14: i56-i68. DOI: 10.1093/Neuonc/Nos102  0.31
2011 Weller M, Hentschel B, Felsberg J, Schackert G, Simon M, Schnell O, Westphal M, Wick W, Pietsch T, Loeffler M, Reifenberger G. Impact of MGMT promoter methylation in glioblastoma of the elderly. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2001. PMID 28023878 DOI: 10.1200/Jco.2011.29.15_Suppl.2001  0.306
2011 Malzkorn B, Wolter M, Riemenschneider MJ, Reifenberger G. Unraveling the glioma epigenome: from molecular mechanisms to novel biomarkers and therapeutic targets. Brain Pathology (Zurich, Switzerland). 21: 619-32. PMID 21939466 DOI: 10.1111/J.1750-3639.2011.00536.X  0.391
2011 Glas M, Bähr O, Felsberg J, Rasch K, Wiewrodt D, Schabet M, Simon M, Urbach H, Steinbach JP, Rieger J, Fimmers R, Bamberg M, Nägele T, Reifenberger G, Weller M, et al. NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri. Annals of Neurology. 70: 445-53. PMID 21710625 DOI: 10.1002/Ana.22478  0.344
2011 Lindemann C, Hackmann O, Delic S, Schmidt N, Reifenberger G, Riemenschneider MJ. SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation Acta Neuropathologica. 122: 241-251. PMID 21590492 DOI: 10.1007/S00401-011-0832-0  0.389
2011 Hartmann C, Hentschel B, Tatagiba M, Schramm J, Schnell O, Seidel C, Stein R, Reifenberger G, Pietsch T, von Deimling A, Loeffler M, Weller M. Molecular markers in low-grade gliomas: predictive or prognostic? Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 4588-99. PMID 21558404 DOI: 10.1158/1078-0432.Ccr-10-3194  0.396
2011 Campos B, Centner FS, Bermejo JL, Ali R, Dorsch K, Wan F, Felsberg J, Ahmadi R, Grabe N, Reifenberger G, Unterberg A, Burhenne J, Herold-Mende C. Aberrant expression of retinoic acid signaling molecules influences patient survival in astrocytic gliomas. The American Journal of Pathology. 178: 1953-64. PMID 21514413 DOI: 10.1016/J.Ajpath.2011.01.051  0.363
2011 Felsberg J, Thon N, Eigenbrod S, Hentschel B, Sabel MC, Westphal M, Schackert G, Kreth FW, Pietsch T, Löffler M, Weller M, Reifenberger G, Tonn JC. Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas. International Journal of Cancer. Journal International Du Cancer. 129: 659-70. PMID 21425258 DOI: 10.1002/Ijc.26083  0.382
2011 Wan F, Herold-Mende C, Campos B, Centner FS, Dictus C, Becker N, Devens F, Mogler C, Felsberg J, Grabe N, Reifenberger G, Lichter P, Unterberg A, Bermejo JL, Ahmadi R. Association of stem cell-related markers and survival in astrocytic gliomas. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 16: 136-43. PMID 21323603 DOI: 10.3109/1354750X.2010.536256  0.374
2011 Schindler G, Capper D, Meyer J, Janzarik W, Omran H, Herold-Mende C, Schmieder K, Wesseling P, Mawrin C, Hasselblatt M, Louis DN, Korshunov A, Pfister S, Hartmann C, Paulus W, ... Reifenberger G, et al. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathologica. 121: 397-405. PMID 21274720 DOI: 10.1007/S00401-011-0802-6  0.421
2011 Campos B, Bermejo JL, Han L, Felsberg J, Ahmadi R, Grabe N, Reifenberger G, Unterberg A, Herold-Mende C. Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas. Cancer Science. 102: 387-92. PMID 21143702 DOI: 10.1111/J.1349-7006.2010.01792.X  0.439
2011 Toedt G, Barbus S, Wolter M, Felsberg J, Tews B, Blond F, Sabel MC, Hofmann S, Becker N, Hartmann C, Ohgaki H, von Deimling A, Wiestler OD, Hahn M, Lichter P, ... Reifenberger G, et al. Molecular signatures classify astrocytic gliomas by IDH1 mutation status. International Journal of Cancer. Journal International Du Cancer. 128: 1095-103. PMID 20473936 DOI: 10.1002/Ijc.25448  0.449
2010 Hartmann C, Hentschel B, Wick W, Capper D, Felsberg J, Simon M, Westphal M, Schackert G, Meyermann R, Pietsch T, Reifenberger G, Weller M, Loeffler M, von Deimling A. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta Neuropathologica. 120: 707-18. PMID 21088844 DOI: 10.1007/S00401-010-0781-Z  0.389
2010 Reifenberger G, Wesseling P. Molecular diagnostics of brain tumors. Acta Neuropathologica. 120: 549-51. PMID 20927631 DOI: 10.1007/S00401-010-0752-4  0.478
2010 Traenka C, Remke M, Korshunov A, Bender S, Hielscher T, Northcott PA, Witt H, Ryzhova M, Felsberg J, Benner A, Riester S, Scheurlen W, Grunewald TG, von Deimling A, Kulozik AE, ... Reifenberger G, et al. Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma. Cancer Research. 70: 8003-14. PMID 20924110 DOI: 10.1158/0008-5472.Can-10-0592  0.405
2010 Riemenschneider MJ, Hegi ME, Reifenberger G. MGMT promoter methylation in malignant gliomas. Targeted Oncology. 5: 161-5. PMID 20725792 DOI: 10.1007/S11523-010-0153-6  0.391
2010 Riemenschneider MJ, Jeuken JW, Wesseling P, Reifenberger G. Molecular diagnostics of gliomas: state of the art. Acta Neuropathologica. 120: 567-84. PMID 20714900 DOI: 10.1007/S00401-010-0736-4  0.444
2010 Korshunov A, Remke M, Werft W, Benner A, Ryzhova M, Witt H, Sturm D, Wittmann A, Schöttler A, Felsberg J, Reifenberger G, Rutkowski S, Scheurlen W, Kulozik AE, von Deimling A, et al. Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 3054-60. PMID 20479417 DOI: 10.1200/Jco.2009.25.7121  0.359
2010 Temme A, Geiger KD, Wiedemuth R, Conseur K, Pietsch T, Felsberg J, Reifenberger G, Tatsuka M, Hagel C, Westphal M, Berger H, Simon M, Weller M, Schackert G. Giant cell glioblastoma is associated with altered aurora b expression and concomitant p53 mutation. Journal of Neuropathology and Experimental Neurology. 69: 632-42. PMID 20467329 DOI: 10.1097/Nen.0B013E3181E4C06E  0.353
2010 Liu HK, Wang Y, Belz T, Bock D, Takacs A, Radlwimmer B, Barbus S, Reifenberger G, Lichter P, Schütz G. The nuclear receptor tailless induces long-term neural stem cell expansion and brain tumor initiation. Genes & Development. 24: 683-95. PMID 20360385 DOI: 10.1101/Gad.560310  0.402
2010 Grzendowski M, Wolter M, Riemenschneider MJ, Knobbe CB, Schlegel U, Meyer HE, Reifenberger G, Stühler K. Differential proteome analysis of human gliomas stratified for loss of heterozygosity on chromosomal arms 1p and 19q. Neuro-Oncology. 12: 243-56. PMID 20167812 DOI: 10.1093/Neuonc/Nop025  0.386
2010 Felsberg J, Wolter M, Seul H, Friedensdorf B, Göppert M, Sabel MC, Reifenberger G. Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing. Acta Neuropathologica. 119: 501-7. PMID 20131059 DOI: 10.1007/S00401-010-0647-4  0.359
2010 Waha A, Felsberg J, Hartmann W, von dem Knesebeck A, Mikeska T, Joos S, Wolter M, Koch A, Yan PS, Endl E, Wiestler OD, Reifenberger G, Pietsch T, Waha A. Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cells. Cancer Research. 70: 1689-99. PMID 20124482 DOI: 10.1158/0008-5472.Can-09-3218  0.45
2010 Riemenschneider MJ, Reifenberger G. Molecular neuropathology of low-grade gliomas and its clinical impact. Advances and Technical Standards in Neurosurgery. 35: 35-64. PMID 20102110 DOI: 10.1007/978-3-211-99481-8_2  0.442
2010 Weller M, Stupp R, Reifenberger G, Brandes AA, van den Bent MJ, Wick W, Hegi ME. MGMT promoter methylation in malignant gliomas: ready for personalized medicine? Nature Reviews. Neurology. 6: 39-51. PMID 19997073 DOI: 10.1038/Nrneurol.2009.197  0.33
2010 Küsters-Vandevelde HV, Klaasen A, Küsters B, Groenen PJ, van Engen-van Grunsven IA, van Dijk MR, Reifenberger G, Wesseling P, Blokx WA. Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system. Acta Neuropathologica. 119: 317-23. PMID 19936769 DOI: 10.1007/S00401-009-0611-3  0.406
2010 Barski D, Wolter M, Reifenberger G, Riemenschneider MJ. Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas. Brain Pathology (Zurich, Switzerland). 20: 623-31. PMID 19922547 DOI: 10.1111/J.1750-3639.2009.00340.X  0.414
2010 Götze S, Wolter M, Reifenberger G, Müller O, Sievers S. Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas. International Journal of Cancer. Journal International Du Cancer. 126: 2584-93. PMID 19847810 DOI: 10.1002/Ijc.24981  0.419
2010 Kurzwelly D, Glas M, Roth P, Weimann E, Lohner H, Waha A, Schabet M, Reifenberger G, Weller M, Herrlinger U. Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status. Journal of Neuro-Oncology. 97: 389-392. PMID 19841864 DOI: 10.1007/S11060-009-0032-0  0.317
2009 Götze S, Feldhaus V, Traska T, Wolter M, Reifenberger G, Tannapfel A, Kuhnen C, Martin D, Müller O, Sievers S. ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma. Bmc Cancer. 9: 447. PMID 20017917 DOI: 10.1186/1471-2407-9-447  0.394
2009 Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, Sabel MC, Koeppen S, Ketter R, Meyermann R, Rapp M, Meisner C, Kortmann RD, Pietsch T, Wiestler OD, ... ... Reifenberger G, et al. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5874-80. PMID 19901110 DOI: 10.1200/Jco.2009.23.6497  0.337
2009 Felsberg J, Rapp M, Loeser S, Fimmers R, Stummer W, Goeppert M, Steiger HJ, Friedensdorf B, Reifenberger G, Sabel MC. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 6683-93. PMID 19861461 DOI: 10.1158/1078-0432.Ccr-08-2801  0.437
2009 Ernst A, Hofmann S, Ahmadi R, Becker N, Korshunov A, Engel F, Hartmann C, Felsberg J, Sabel M, Peterziel H, Durchdewald M, Hess J, Barbus S, Campos B, Starzinski-Powitz A, ... ... Reifenberger G, et al. Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 6541-50. PMID 19861460 DOI: 10.1158/1078-0432.Ccr-09-0695  0.413
2009 Grzendowski M, Riemenschneider MJ, Hawranke E, Stefanski A, Meyer HE, Reifenberger G, Stühler K. Simultaneous extraction of nucleic acids and proteins from tissue specimens by ultracentrifugation: A protocol using the high-salt protein fraction for quantitative proteome analysis Proteomics. 9: 4985-4990. PMID 19810030 DOI: 10.1002/Pmic.200800902  0.328
2009 Weller M, Felsberg J, Hartmann C, Berger H, Steinbach JP, Schramm J, Westphal M, Schackert G, Simon M, Tonn JC, Heese O, Krex D, Nikkhah G, Pietsch T, Wiestler O, ... Reifenberger G, et al. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5743-50. PMID 19805672 DOI: 10.1200/Jco.2009.23.0805  0.391
2009 Riemenschneider MJ, Reifenberger G. Novel insights into the pathogenesis of gliomas based on large-scale molecular profiling approaches. Current Opinion in Neurology. 22: 619-624. PMID 19741528 DOI: 10.1097/Wco.0B013E32833245B0  0.382
2009 Riemenschneider MJ, Beseoglu K, Hänggi D, Reifenberger G. Prostate Adenocarcinoma Metastasis in the Pituitary Gland Jama Neurology. 66: 1036-1036. PMID 19667229 DOI: 10.1001/Archneurol.2009.146  0.322
2009 Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, Felsberg J, Wolter M, Mawrin C, Wick W, Weller M, Herold-Mende C, Unterberg A, Jeuken JW, Wesseling P, ... Reifenberger G, et al. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathologica. 118: 469-74. PMID 19554337 DOI: 10.1007/S00401-009-0561-9  0.341
2009 Riemenschneider MJ, Reifenberger G. Molecular neuropathology of gliomas. International Journal of Molecular Sciences. 10: 184-212. PMID 19333441 DOI: 10.3390/Ijms10010184  0.439
2009 Riemenschneider MJ, Reifenberger G. Astrocytic tumors. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer. 171: 3-24. PMID 19322535 DOI: 10.1007/978-3-540-31206-2_1  0.319
2009 Scholz M, Hoischen A, Radlwimmer B, Weber RG, Harders A, Reifenberger G, Riemenschneider MJ. Rosetted glioneuronal tumor of the spine with overtly anaplastic histological features. Acta Neuropathologica. 117: 591-3. PMID 19266208 DOI: 10.1007/S00401-009-0510-7  0.376
2009 Pfister S, Remke M, Benner A, Mendrzyk F, Toedt G, Felsberg J, Wittmann A, Devens F, Gerber NU, Joos S, Kulozik A, Reifenberger G, Rutkowski S, Wiestler OD, Radlwimmer B, et al. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci Journal of Clinical Oncology. 27: 1627-1636. PMID 19255330 DOI: 10.1200/Jco.2008.17.9432  0.348
2009 Koga T, Morita A, Maruyama K, Tanaka M, Ino Y, Shibahara J, Louis DN, Reifenberger G, Itami J, Hara R, Saito N, Todo T. Long-term control of disseminated pleomorphic xanthoastrocytoma with anaplastic features by means of stereotactic irradiation. Neuro-Oncology. 11: 446-51. PMID 19164434 DOI: 10.1215/15228517-2008-112  0.355
2009 Rickert CH, Riemenschneider MJ, Schachenmayr W, Richter HP, Bockhorn J, Reifenberger G, Paulus W. Glioblastoma with adipocyte-like tumor cell differentiation--histological and molecular features of a rare differentiation pattern. Brain Pathology (Zurich, Switzerland). 19: 431-8. PMID 18691268 DOI: 10.1111/J.1750-3639.2008.00199.X  0.443
2009 Ness JS, Riemenschneider MJ, Baches S, Eriksen JL, Pietrzik CU, Reifenberger G, Weggen S. P4-244: Progranulin (GRN), a protein mutated in frontotemporal dementia with ubiquitin-positive inclusions (FTLD-U), is abundantly expressed in human gliomas Alzheimer's & Dementia. 5: P502-P502. DOI: 10.1016/J.Jalz.2009.04.710  0.301
2008 Grund K, Ahmadi R, Jung F, Funke V, Gdynia G, Benner A, Sykora J, Walczak H, Joos S, Felsberg J, Reifenberger G, Wiestler OD, Herold-Mende C, Roth W. Troglitazone-mediated sensitization to TRAIL-induced apoptosis is regulated by proteasome-dependent degradation of FLIP and ERK1/2-dependent phosphorylation of BAD. Cancer Biology & Therapy. 7: 1982-1990. PMID 19158480 DOI: 10.4161/Cbt.7.12.6966  0.323
2008 Tepel M, Roerig P, Wolter M, Gutmann DH, Perry A, Reifenberger G, Riemenschneider MJ. Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma. International Journal of Cancer. 123: 2080-6. PMID 18709645 DOI: 10.1002/Ijc.23705  0.433
2008 Beier D, Röhrl S, Pillai DR, Schwarz S, Kunz-Schughart LA, Leukel P, Proescholdt M, Brawanski A, Bogdahn U, Trampe-Kieslich A, Giebel B, Wischhusen J, Reifenberger G, Hau P, Beier CP. Temozolomide preferentially depletes cancer stem cells in glioblastoma Cancer Research. 68: 5706-5715. PMID 18632623 DOI: 10.1158/0008-5472.Can-07-6878  0.394
2008 Toepoel M, Joosten PHLJ, Knobbe CB, Afink GB, Zotz RB, Steegers-Theunissen RPM, Reifenberger G, Zoelen EJJv. Haplotype-specific expression of the human PDGFRA gene correlates with the risk of glioblastomas International Journal of Cancer. 123: 322-329. PMID 18464291 DOI: 10.1002/Ijc.23432  0.324
2008 Schittenhelm J, Reifenberger G, Ritz R, Nägele T, Weller M, Pantazis G, Capper D, Beschorner R, Meyermann R, Mittelbronn M. Primary anaplastic ganglioglioma with a small-cell glioblastoma component. Clinical Neuropathology. 27: 91-95. PMID 18402388 DOI: 10.5414/Npp27091  0.359
2008 Preusser M, Janzer RC, Felsberg J, Reifenberger G, Hamou M, Diserens A, Stupp R, Gorlia T, Marosi C, Heinzl H, Hainfellner JA, Hegi M. Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker. Brain Pathology. 18: 520-532. PMID 18400046 DOI: 10.1111/J.1750-3639.2008.00153.X  0.353
2008 Pfister S, Janzarik WG, Remke M, Ernst A, Werft W, Becker N, Toedt G, Wittmann A, Kratz C, Olbrich H, Ahmadi R, Thieme B, Joos S, Radlwimmer B, Kulozik A, ... ... Reifenberger G, et al. BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. The Journal of Clinical Investigation. 118: 1739-49. PMID 18398503 DOI: 10.1172/Jci33656  0.444
2008 Dehnhardt M, Zoriy MV, Khan Z, Reifenberger G, Ekström TJ, Sabine Becker J, Zilles K, Bauer A. Element distribution is altered in a zone surrounding human glioblastoma multiforme. Journal of Trace Elements in Medicine and Biology : Organ of the Society For Minerals and Trace Elements (Gms). 22: 17-23. PMID 18319136 DOI: 10.1016/J.Jtemb.2007.08.002  0.323
2008 Riemenschneider MJ, Reifenberger J, Reifenberger G. Frequent biallelic inactivation and transcriptional silencing of the DIRAS3 gene at 1p31 in oligodendroglial tumors with 1p loss. International Journal of Cancer. 122: 2503-2510. PMID 18302158 DOI: 10.1002/Ijc.23409  0.438
2008 Montesinos-Rongen M, Brunn A, Bentink S, Basso K, Lim WK, Klapper W, Schaller C, Reifenberger G, Rubenstein J, Wiestler OD, Spang R, Dalla-Favera R, Siebert R, Deckert M. Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell. Leukemia. 22: 400-5. PMID 17989719 DOI: 10.1038/Sj.Leu.2405019  0.307
2007 Schlierf B, Friedrich RP, Roerig P, Felsberg J, Reifenberger G, Wegner M. Expression of SoxE and SoxD genes in human gliomas. Neuropathology and Applied Neurobiology. 33: 621-30. PMID 17961134 DOI: 10.1111/J.1365-2990.2007.00881.X  0.363
2007 Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G, Weller M, Schackert G. Long-term survival with glioblastoma multiforme. Brain : a Journal of Neurology. 130: 2596-606. PMID 17785346 DOI: 10.1093/Brain/Awm204  0.333
2007 Grasbon-Frodl EM, Kreth FW, Ruiter M, Schnell O, Bise K, Felsberg J, Reifenberger G, Tonn JC, Kretzschmar HA. Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas. International Journal of Cancer. Journal International Du Cancer. 121: 2458-64. PMID 17691113 DOI: 10.1002/Ijc.23020  0.417
2007 Brunn A, Montesinos-Rongen M, Strack A, Reifenberger G, Mawrin C, Schaller C, Deckert M. Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma. Acta Neuropathologica. 114: 271-6. PMID 17641901 DOI: 10.1007/S00401-007-0258-X  0.35
2007 Kunitz A, Wolter M, van den Boom J, Felsberg J, Tews B, Hahn M, Benner A, Sabel M, Lichter P, Reifenberger G, von Deimling A, Hartmann C. DNA hypermethylation and aberrant expression of the EMP3 gene at 19q13.3 in Human Gliomas. Brain Pathology (Zurich, Switzerland). 17: 363-70. PMID 17610521 DOI: 10.1111/J.1750-3639.2007.00083.X  0.421
2007 Boulay JL, Miserez AR, Zweifel C, Sivasankaran B, Kana V, Ghaffari A, Luyken C, Sabel M, Zerrouqi A, Wasner M, Van Meir E, Tolnay M, Reifenberger G, Merlo A. Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumors. Plos One. 2: e576. PMID 17593975 DOI: 10.1371/Journal.Pone.0000576  0.362
2007 Kros JM, Gorlia T, Kouwenhoven MC, Zheng PP, Collins VP, Figarella-Branger D, Giangaspero F, Giannini C, Mokhtari K, Mørk SJ, Paetau A, Reifenberger G, van den Bent MJ. Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome. Journal of Neuropathology and Experimental Neurology. 66: 545-51. PMID 17549014 DOI: 10.1097/01.Jnen.0000263869.84188.72  0.374
2007 Floeth FW, Pauleit D, Sabel M, Stoffels G, Reifenberger G, Riemenschneider MJ, Jansen P, Coenen HH, Steiger H, Langen K. Prognostic Value of O-(2-18F-Fluoroethyl)-l-Tyrosine PET and MRI in Low-Grade Glioma The Journal of Nuclear Medicine. 48: 519-527. PMID 17401087 DOI: 10.2967/Jnumed.106.037895  0.306
2007 Courts C, Montesinos-Rongen M, Martin-Subero JI, Brunn A, Siemer D, Zühlke-Jenisch R, Pels H, Jürgens A, Schlegel U, Schmidt-Wolf IG, Schaller C, Reifenberger G, Sabel M, Warnecke-Eberz U, Wiestler OD, et al. Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expression. Journal of Neuropathology and Experimental Neurology. 66: 230-7. PMID 17356384 DOI: 10.1097/01.Jnen.0000248553.45456.96  0.302
2007 Tews B, Roerig P, Hartmann C, Hahn M, Felsberg J, Blaschke B, Sabel M, Kunitz A, Toedt G, Neben K, Benner A, von Deimling A, Reifenberger G, Lichter P. Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q. Oncogene. 26: 5010-6. PMID 17311001 DOI: 10.1038/Sj.Onc.1210297  0.36
2007 Trost D, Ehrler M, Fimmers R, Felsberg J, Sabel MC, Kirsch L, Schramm J, Wiestler OD, Reifenberger G, Weber RG. Identification of genomic aberrations associated with shorter overall survival in patients with oligodendroglial tumors. International Journal of Cancer. Journal International Du Cancer. 120: 2368-76. PMID 17285580 DOI: 10.1002/Ijc.22574  0.378
2007 Sharma MK, Mansur DB, Reifenberger G, Perry A, Leonard JR, Aldape KD, Albin MG, Emnett RJ, Loeser S, Watson MA, Nagarajan R, Gutmann DH. Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin. Cancer Research. 67: 890-900. PMID 17283119 DOI: 10.1158/0008-5472.Can-06-0973  0.41
2007 Riemenschneider MJ, Perry A, Reifenberger G. Histological classification and molecular genetics of meningiomas. The Lancet. Neurology. 5: 1045-54. PMID 17110285 DOI: 10.1016/S1474-4422(06)70625-1  0.375
2007 Distelmaier F, Fahsold R, Reifenberger G, Messing-Juenger M, Schaper J, Schneider DT, Göbel U, Mayatepek E, Rosenbaum T. Fatal glioblastoma multiforme in a patient with neurofibromatosis type I: the dilemma of systematic medical follow-up. Child's Nervous System : Chns : Official Journal of the International Society For Pediatric Neurosurgery. 23: 343-7. PMID 17009007 DOI: 10.1007/S00381-006-0222-4  0.346
2007 Weber RG, Hoischen A, Ehrler M, Zipper P, Kaulich K, Blaschke B, Becker AJ, Weber-Mangal S, Jauch A, Radlwimmer B, Schramm J, Wiestler OD, Lichter P, Reifenberger G. Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas. Oncogene. 26: 1088-97. PMID 16909113 DOI: 10.1038/Sj.Onc.1209851  0.383
2006 Felsberg J, Yan PS, Huang TH, Milde U, Schramm J, Wiestler OD, Reifenberger G, Pietsch T, Waha A. DNA methylation and allelic losses on chromosome arm 14q in oligodendroglial tumours. Neuropathology and Applied Neurobiology. 32: 517-24. PMID 16972885 DOI: 10.1111/J.1365-2990.2006.00759.X  0.328
2006 Boom Jvd, Wolter M, Blaschke B, Knobbe CB, Reifenberger G. Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real‐time reverse transcription‐polymerase chain reaction International Journal of Cancer. 119: 2330-2338. PMID 16865689 DOI: 10.1002/Ijc.22108  0.43
2006 Messing-Jünger AM, Riemenschneider MJ, Reifenberger G. A 21-year-old female with a third ventricular tumor. Brain Pathology. 16: 87-88. PMID 16612987 DOI: 10.1111/J.1750-3639.2006.Tb00566.X  0.403
2006 Schneider DT, Zahn S, Sievers S, Alemazkour K, Reifenberger G, Wiestler OD, Calaminus G, Göbel U, Perlman EJ. Molecular genetic analysis of central nervous system germ cell tumors with comparative genomic hybridization. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 19: 864-73. PMID 16607373 DOI: 10.1038/Modpathol.3800607  0.417
2006 Tews B, Felsberg J, Hartmann C, Kunitz A, Hahn M, Toedt G, Neben K, Hummerich L, von Deimling A, Reifenberger G, Lichter P. Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling. International Journal of Cancer. Journal International Du Cancer. 119: 792-800. PMID 16550607 DOI: 10.1002/Ijc.21901  0.393
2006 Ehrbrecht A, Müller U, Wolter M, Hoischen A, Koch A, Radlwimmer B, Actor B, Mincheva A, Pietsch T, Lichter P, Reifenberger G, Weber RG. Comprehensive genomic analysis of desmoplastic medulloblastomas: identification of novel amplified genes and separate evaluation of the different histological components. The Journal of Pathology. 208: 554-63. PMID 16400626 DOI: 10.1002/Path.1925  0.332
2006 Knobbe CB, Reifenberger G. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3'-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathology. 13: 507-518. PMID 14655756 DOI: 10.1111/J.1750-3639.2003.Tb00481.X  0.383
2005 Mendrzyk F, Radlwimmer B, Joos S, Kokocinski F, Benner A, Stange DE, Neben K, Fiegler H, Carter NP, Reifenberger G, Korshunov A, Lichter P. Genomic and Protein Expression Profiling Identifies CDK6 As Novel Independent Prognostic Marker in Medulloblastoma Journal of Clinical Oncology. 23: 8853-8862. PMID 16314645 DOI: 10.1200/Jco.2005.02.8589  0.392
2005 Knobbe CB, Trampe‐Kieslich A, Reifenberger G. Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas. Neuropathology and Applied Neurobiology. 31: 486-490. PMID 16150119 DOI: 10.1111/J.1365-2990.2005.00660.X  0.361
2005 Lusis EA, Watson MA, Chicoine MR, Lyman M, Roerig P, Reifenberger G, Gutmann DH, Perry A. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Research. 65: 7121-6. PMID 16103061 DOI: 10.1158/0008-5472.Can-05-0043  0.429
2005 Montesinos-Rongen M, Schmitz R, Courts C, Stenzel W, Bechtel D, Niedobitek G, Blümcke I, Reifenberger G, von Deimling A, Jungnickel B, Wiestler OD, Küppers R, Deckert M. Absence of immunoglobulin class switch in primary lymphomas of the central nervous system. The American Journal of Pathology. 166: 1773-9. PMID 15920162 DOI: 10.1016/S0002-9440(10)62487-X  0.373
2005 Roerig P, Nessling M, Radlwimmer B, Joos S, Wrobel G, Schwaenen C, Reifenberger G, Lichter P. Molecular classification of human gliomas using matrix-based comparative genomic hybridization International Journal of Cancer. 117: 95-103. PMID 15880582 DOI: 10.1002/Ijc.21121  0.376
2005 Floeth FW, Pauleit D, Wittsack HJ, Langen KJ, Reifenberger G, Hamacher K, Messing-Jünger M, Zilles K, Weber F, Stummer W, Steiger HJ, Woebker G, Müller HW, Coenen H, Sabel M. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. Journal of Neurosurgery. 102: 318-27. PMID 15739561 DOI: 10.3171/Jns.2005.102.2.0318  0.307
2005 Reifenberger J, Wolter M, Knobbe CB, Köhler B, Schönicke A, Scharwächter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas British Journal of Dermatology. 152: 43-51. PMID 15656799 DOI: 10.1111/J.1365-2133.2005.06353.X  0.327
2005 Wrobel G, Roerig P, Kokocinski F, Neben K, Hahn M, Reifenberger G, Lichter P. Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression International Journal of Cancer. 114: 249-256. PMID 15540215 DOI: 10.1002/Ijc.20733  0.378
2005 Möllemann M, Wolter M, Felsberg J, Collins VP, Reifenberger G. Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors. International Journal of Cancer. Journal International Du Cancer. 113: 379-85. PMID 15455350 DOI: 10.1002/Ijc.20575  0.435
2004 Perry A, Gutmann DH, Reifenberger G. Molecular pathogenesis of meningiomas Journal of Neuro-Oncology. 70: 183-202. PMID 15674477 DOI: 10.1007/S11060-004-2749-0  0.419
2004 Knobbe CB, Reifenberger J, Reifenberger G. Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas. Acta Neuropathologica. 108: 467-470. PMID 15517309 DOI: 10.1007/S00401-004-0929-9  0.335
2004 Pauleit D, Langen K, Floeth F, Hautzel H, Riemenschneider MJ, Reifenberger G, Shah NJ, Müller H. Can the apparent diffusion coefficient be used as a noninvasive parameter to distinguish tumor tissue from peritumoral tissue in cerebral gliomas Journal of Magnetic Resonance Imaging. 20: 758-764. PMID 15503327 DOI: 10.1002/Jmri.20177  0.335
2004 Horstmann S, Perry A, Reifenberger G, Giangaspero F, Huang H, Hara A, Masuoka J, Rainov NG, Bergmann M, Heppner FL, Brandner S, Chimelli L, Montagna N, Jackson T, Davis DG, et al. Genetic and expression profiles of cerebellar liponeurocytomas. Brain Pathology (Zurich, Switzerland). 14: 281-9. PMID 15446583 DOI: 10.1111/J.1750-3639.2004.Tb00065.X  0.385
2004 Reifenberger G, Collins VP. Pathology and molecular genetics of astrocytic gliomas. Journal of Molecular Medicine (Berlin, Germany). 82: 656-70. PMID 15316624 DOI: 10.1007/S00109-004-0564-X  0.35
2004 Köhler B, Wolter M, Blaschke B, Reifenberger G. Absence of mutations in the putative tumor suppressor gene KLF6 in glioblastomas and meningiomas. International Journal of Cancer. 111: 644-645. PMID 15239147 DOI: 10.1002/Ijc.20302  0.397
2004 Felsberg J, Erkwoh A, Sabel MC, Kirsch L, Fimmers R, Blaschke B, Schlegel U, Schramm J, Wiestler OD, Reifenberger G. Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival. Brain Pathology. 14: 121-130. PMID 15193024 DOI: 10.1111/J.1750-3639.2004.Tb00044.X  0.374
2004 Stemmer-Rachamimov AO, Louis DN, Nielsen GP, Antonescu CR, Borowsky AD, Bronson RT, Burns DK, Cervera P, McLaughlin ME, Reifenberger G, Schmale MC, MacCollin M, Chao RC, Cichowski K, Kalamarides M, et al. Comparative pathology of nerve sheath tumors in mouse models and humans. Cancer Research. 64: 3718-24. PMID 15150133 DOI: 10.1158/0008-5472.Can-03-4079  0.339
2004 Schaefer KL, Brachwitz K, Wai DH, Braun Y, Diallo R, Korsching E, Eisenacher M, Voss R, Van Valen F, Baer C, Selle B, Spahn L, Liao SK, Lee KA, Hogendoorn PC, ... Reifenberger G, et al. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3. Cancer Research. 64: 3395-405. PMID 15150091 DOI: 10.1158/0008-5472.Can-03-0809  0.421
2004 Knobbe CB, Reifenberger J, Blaschke B, Reifenberger G. Hypermethylation and Transcriptional Downregulation of the Carboxyl-Terminal Modulator Protein Gene in Glioblastomas Journal of the National Cancer Institute. 96: 483-486. PMID 15026474 DOI: 10.1093/Jnci/Djh064  0.403
2004 Reifenberger J, Knobbe CB, Sterzinger AA, Blaschke B, Schulte KW, Ruzicka T, Reifenberger G. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas. International Journal of Cancer. 109: 377-384. PMID 14961576 DOI: 10.1002/Ijc.11722  0.38
2004 Riemenschneider MJ, Koy TH, Reifenberger G. Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomas. Acta Neuropathologica. 107: 277-282. PMID 14730454 DOI: 10.1007/S00401-003-0809-8  0.4
2003 Zhou XP, Marsh DJ, Morrison CD, Chaudhury AR, Maxwell M, Reifenberger G, Eng C. Germline Inactivation of PTEN and Dysregulation of the Phosphoinositol-3-Kinase/Akt Pathway Cause Human Lhermitte-Duclos Disease in Adults American Journal of Human Genetics. 73: 1191-1198. PMID 14566704 DOI: 10.1086/379382  0.312
2003 van den Boom J, Wolter M, Kuick R, Misek DE, Youkilis AS, Wechsler DS, Sommer C, Reifenberger G, Hanash SM. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. The American Journal of Pathology. 163: 1033-43. PMID 12937144 DOI: 10.1016/S0002-9440(10)63463-3  0.372
2003 Wolter M, Scharwächter C, Reifenberger J, Koch A, Pietsch T, Reifenberger G. Absence of detectable alterations in the putative tumor suppressor gene BTRC in cerebellar medulloblastomas and cutaneous basal cell carcinomas. Acta Neuropathologica. 106: 287-90. PMID 12898158 DOI: 10.1007/S00401-003-0745-7  0.443
2003 Floeth F, Langen KJ, Reifenberger G, Weber F. Tumor-free survival of 7 years after gene therapy for recurrent glioblastoma. Neurology. 61: 270-271. PMID 12874421 DOI: 10.1212/01.Wnl.0000069926.27137.Ef  0.377
2003 Reifenberger J, Rauch L, Beckmann MW, Megahed M, Ruzicka T, Reifenberger G. Cowden's disease: clinical and molecular genetic findings in a patient with a novel PTEN germline mutation. British Journal of Dermatology. 148: 1040-1046. PMID 12786840 DOI: 10.1046/J.1365-2133.2003.05322.X  0.321
2003 Riemenschneider MJ, Knobbe CB, Reifenberger G. Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target International Journal of Cancer. 104: 752-757. PMID 12640683 DOI: 10.1002/Ijc.11023  0.38
2003 Reifenberger G, Kaulich K, Wiestler OD, Blümcke I. Expression of the CD34 antigen in pleomorphic xanthoastrocytomas. Acta Neuropathologica. 105: 358-64. PMID 12624789 DOI: 10.1007/S00401-002-0652-3  0.328
2003 Reifenberger G, Louis DN. Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology. Journal of Neuropathology and Experimental Neurology. 62: 111-26. PMID 12578221 DOI: 10.1093/Jnen/62.2.111  0.434
2002 Kaulich K, Blaschke B, Nümann A, von Deimling A, Wiestler OD, Weber RG, Reifenberger G. Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas. Journal of Neuropathology and Experimental Neurology. 61: 1092-9. PMID 12484572 DOI: 10.1093/Jnen/61.12.1092  0.392
2002 Herrlinger U, Felsberg J, Küker W, Bornemann A, Plasswilm L, Knobbe CB, Strik H, Wick W, Meyermann R, Dichgans J, Bamberg M, Reifenberger G, Weller M. Gliomatosis cerebri: molecular pathology and clinical course. Annals of Neurology. 52: 390-9. PMID 12325066 DOI: 10.1002/Ana.10297  0.392
2002 Kraus JA, Felsberg J, Tonn JC, Reifenberger G, Pietsch T. Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4 and MDM2 tumour-associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhood Neuropathology and Applied Neurobiology. 28: 325-333. PMID 12175345 DOI: 10.1046/J.1365-2990.2002.00413.X  0.387
2002 Reifenberger J, Knobbe CB, Wolter M, Blaschke B, Schulte KW, Pietsch T, Ruzicka T, Reifenberger G. Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC. International Journal of Cancer. 100: 549-556. PMID 12124804 DOI: 10.1002/Ijc.10512  0.414
2002 Actor B, Cobbers JM, Büschges R, Wolter M, Knobbe CB, Lichter P, Reifenberger G, Weber RG. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components. Genes, Chromosomes & Cancer. 34: 416-27. PMID 12112531 DOI: 10.1002/Gcc.10087  0.36
2002 Büschges R, Ichimura K, Weber RG, Reifenberger G, Collins VP. Allelic gain and amplification on the long arm of chromosome 17 in anaplastic meningiomas. Brain Pathology (Zurich, Switzerland). 12: 145-53. PMID 11958368 DOI: 10.1111/J.1750-3639.2002.Tb00429.X  0.365
2002 Krajewska M, Zapata JM, Meinhold-Heerlein I, Hedayat H, Monks A, Bettendorf H, Shabaik A, Bubendorf L, Kallioniemi OP, Kim H, Reifenberger G, Reed JC, Krajewski S. Expression of Bcl-2 family member Bid in normal and malignant tissues. Neoplasia (New York, N.Y.). 4: 129-40. PMID 11896568 DOI: 10.1038/Sj.Neo.7900222  0.374
2002 Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK. The WHO classification of tumors of the nervous system. Journal of Neuropathology and Experimental Neurology. 61: 215-25; discussion 2. PMID 11895036 DOI: 10.1093/Jnen/61.3.215  0.41
2002 Giangaspero F, Kaulich K, Cenacchi G, Cerasoli S, Lerch KD, Breu H, Reuter T, Reifenberger G. Lipoastrocytoma: a rare low-grade astrocytoma variant of pediatric age. Acta Neuropathologica. 103: 152-6. PMID 11810181 DOI: 10.1007/S004010100445  0.415
2002 Knobbe CB, Merlo A, Reifenberger G. Pten signaling in gliomas. Neuro-Oncology. 4: 196-211. DOI: 10.1093/Neuonc/4.3.196  0.408
2002 Felsberg J, Reifenberger G. Neuropathology and Molecular Genetics of Diffusely Infiltrating Cerebral Gliomas Medical Laser Application. 17: 133-146. DOI: 10.1078/1615-1615-00056  0.417
2001 Wolter M, Reifenberger J, Blaschke B, Ichimura K, Schmidt EE, Collins VP, Reifenberger G. Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes. Journal of Neuropathology and Experimental Neurology. 60: 1170-80. PMID 11764089 DOI: 10.1093/Jnen/60.12.1170  0.432
2001 Schmidt D, Gottwald U, Langen KJ, Weber F, Hertel A, Floeth F, Felsberg J, Reifenberger G, Coenen HH, Müller-Gärtner H. 3-[123I]Iodo-α-methyl-L-tyrosine uptake in cerebral gliomas: Relationship to histological grading and prognosis European Journal of Nuclear Medicine. 28: 855-861. PMID 11504082 DOI: 10.1007/S002590100553  0.349
2001 Boström J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P, Ichimura K, Collins VP, Reifenberger G. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. The American Journal of Pathology. 159: 661-9. PMID 11485924 DOI: 10.1016/S0002-9440(10)61737-3  0.337
2001 Sabel M, Reifenberger J, Weber RG, Reifenberger G, Schmitt HP. Long-term survival of a patient with giant cell glioblastoma. Case report. Journal of Neurosurgery. 94: 605-11. PMID 11302659 DOI: 10.3171/Jns.2001.94.4.0605  0.453
2000 Rademacher J, Aulich A, Reifenberger G, Kiwit JCW, Langen KJ, Schmidt D, Seitz RJ. Focal cortical dysplasia of the temporal lobe with late-onset partial epilepsy: Serial quantitative MRI Neuroradiology. 42: 430-435. PMID 10929303 DOI: 10.1007/S002340000304  0.448
2000 Weber T, Weber RG, Kaulich K, Actor B, Meyer-Puttlitz B, Lampel S, Büschges R, Weigel R, Deckert-Schlüter M, Schmiedek P, Reifenberger G, Lichter P. Characteristic chromosomal imbalances in primary central nervous system lymphomas of the diffuse large B-cell type. Brain Pathology (Zurich, Switzerland). 10: 73-84. PMID 10668897 DOI: 10.1111/J.1750-3639.2000.Tb00244.X  0.381
1998 Weber RG, Bridger JM, Benner A, Weisenberger D, Ehemann V, Reifenberger G, Lichter P. Centrosome amplification as a possible mechanism for numerical chromosome aberrations in cerebral primitive neuroectodermal tumors with TP53 mutations. Cytogenetics and Cell Genetics. 83: 266-9. PMID 10072601 DOI: 10.1159/000015168  0.398
1998 Weber RG, Scheer M, Born IA, Joos S, Cobbers JM, Hofele C, Reifenberger G, Zöller JE, Lichter P. Recurrent chromosomal imbalances detected in biopsy material from oral premalignant and malignant lesions by combined tissue microdissection, universal DNA amplification, and comparative genomic hybridization. The American Journal of Pathology. 153: 295-303. PMID 9665491 DOI: 10.1016/S0002-9440(10)65571-X  0.301
1998 Reifenberger J, Janssen G, Weber RG, Boström J, Engelbrecht V, Lichter P, Borchard F, Göbel U, Lenard HG, Reifenberger G. Primitive neuroectodermal tumors of the cerebral hemispheres in two siblings with TP53 germline mutation. Journal of Neuropathology and Experimental Neurology. 57: 179-87. PMID 9600210 DOI: 10.1097/00005072-199802000-00009  0.401
1998 Cobbers JM, Wolter M, Reifenberger J, Ring GU, Jessen F, An HX, Niederacher D, Schmidt EE, Ichimura K, Floeth F, Kirsch L, Borchard F, Louis DN, Collins VP, Reifenberger G. Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL. Brain Pathology (Zurich, Switzerland). 8: 263-76. PMID 9546285 DOI: 10.1111/J.1750-3639.1998.Tb00152.X  0.454
1998 Reifenberger J, Wolter M, Schulte KW, Megahed M, Ruzicka T, Reifenberger G. Mutational analysis of the SHH and PTCH genes in sporadic basal cell carcinomas Journal of Dermatological Science. 16. DOI: 10.1016/S0923-1811(98)83850-4  0.305
1997 Weber RG, Boström J, Wolter M, Baudis M, Collins VP, Reifenberger G, Lichter P. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proceedings of the National Academy of Sciences of the United States of America. 94: 14719-24. PMID 9405679 DOI: 10.1073/Pnas.94.26.14719  0.338
1996 Reifenberger J, Ring GU, Gies U, Cobbers L, Oberstrass J, An HX, Niederacher D, Wechsler W, Reifenberger G. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. Journal of Neuropathology and Experimental Neurology. 55: 822-31. PMID 8965097  0.611
1996 Reifenberger G, Boström J, Bettag M, Bock WJ, Wechsler W, Kepes JJ. Primary glioblastoma multiforme of the oculomotor nerve. Case report. Journal of Neurosurgery. 84: 1062-6. PMID 8847574 DOI: 10.3171/Jns.1996.84.6.1062  0.549
1996 Fredman P, Wikstrand CJ, MÃ¥nsson JE, Reifenberger G, Bigner SH, Rasheed A, Svennerholm L, Bigner DD. In vivo growth conditions suppress the expression of ganglioside GM2 and favour that of lacto series gangliosides in the human glioma D-54MG cell line. Glycoconjugate Journal. 13: 391-9. PMID 8781970 DOI: 10.1007/Bf00731472  0.306
1996 Oberstrass J, Reifenberger G, Reifenberger J, Wechsler W, Collins VP. Mutation of the Von Hippel-Lindau tumour suppressor gene in capillary haemangioblastomas of the central nervous system. The Journal of Pathology. 179: 151-6. PMID 8758206 DOI: 10.1002/(SICI)1096-9896(199606)179:2<151::AID-PATH556>3.0.CO;2-0  0.519
1996 Reifenberger J, Reifenberger G, Ichimura K, Schmidt EE, Wechsler W, Collins VP. Epidermal growth factor receptor expression in oligodendroglial tumors. The American Journal of Pathology. 149: 29-35. PMID 8686753  0.553
1995 Schober R, Bilzer T, Waha A, Reifenberger G, Wechsler W, von Deimling A, Wiestler OD, Westphal M, Kemshead JT, Vega F. The epidermal growth factor receptor in glioblastoma: genomic amplification, protein expression, and patient survival data in a therapeutic trial. Clinical Neuropathology. 14: 169-74. PMID 7671460  0.54
1995 Reifenberger G, Reifenberger J, Bilzer T, Wechsler W, Collins VP. Coexpression of transforming growth factor-alpha and épidermal growth factor receptor in capillary hemangioblastomas of the central nervous system. The American Journal of Pathology. 147: 245-50. PMID 7639324  0.504
1994 Westphal M, Hamel W, Zirkel D, Herrmann HD, Bilzer T, Reifenberger G, Schober R, Wechsler W, Albert FK, Behnke J. Epidermal growth factor receptor expression in human malignant glioma: in vitro and in vivo effects of application of monoclonal antibodies to the epidermal growth factor receptor. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrã¨S Dans Les Recherches Sur Le Cancer. 135: 171-84. PMID 8047692  0.483
1994 Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. The American Journal of Pathology. 145: 1175-90. PMID 7977648  0.585
1993 Schober R, Reifenberger G, Kremer G, Urich H. Symmetrical neurofibroma with Schwann cell predominance and focal formation of microneurinomas. Acta Neuropathologica. 85: 227-32. PMID 8442415 DOI: 10.1007/Bf00227773  0.303
1993 Hanemann CO, Kleinschmidt A, Reifenberger G, Freund HJ, Seitz RJ. Balo's concentric sclerosis followed by MRI and positron emission tomography. Neuroradiology. 35: 578-80. PMID 8278034 DOI: 10.1007/Bf00588396  0.462
1993 Schober R, Bilzer T, Reifenberger G, Vogeley KT, Wechsler W, Reiffen K-. EPIDERMAL GROWTH FACTOR RECEPTOR EXPRESSION IN GLIOBLASTOMAS Journal of Neuropathology and Experimental Neurology. 52: 291. DOI: 10.1097/00005072-199305000-00122  0.525
1992 Figge C, Reifenberger G, Vogeley KT, Messing M, Roosen N, Wechsler W. Immunohistochemical demonstration of proliferating cell nuclear antigen in glioblastomas: pronounced heterogeneity and lack of prognostic significance. Journal of Cancer Research and Clinical Oncology. 118: 289-95. PMID 1374410 DOI: 10.1007/Bf01208618  0.582
1992 Reifenberger G, Sieth P, Niederhaus M, Wechsler W. Expression of CD15 in tumours of the nervous system. The Histochemical Journal. 24: 890-901. PMID 1362199 DOI: 10.1007/Bf01046360  0.564
1991 Vogeley KT, Bilzer T, Reifenberger G, Wechsler W. Immunochemistry of ethylnitrosourea-induced rat neurinomas, the RN6 neurinoma cell line and their transplantation tumors. Acta Neuropathologica. 82: 78-85. PMID 1719740 DOI: 10.1007/Bf00310927  0.601
1991 Kiwit JCW, Schmitz K, Daum L, Reifenberger G, Roosen N. Effects of recombinant human tumor necrosis factor on rodent gliomas and normal brain. Journal of Neurosurgery. 75: 597-603. PMID 1653310 DOI: 10.3171/Jns.1991.75.4.0597  0.36
1990 Tajika Y, Reifenberger G, Kiwit JC, Wechsler W. Metastatic adenocarcinoma in cerebral astrocytoma: clinicopathological and immunohistochemical study with review of the literature. Acta Neurochirurgica. 105: 50-5. PMID 2239381 DOI: 10.1007/Bf01664858  0.558
1990 Prior R, Reifenberger G, Wechsler W. Transferrin receptor expression in tumours of the human nervous system: relation to tumour type, grading and tumour growth fraction. Virchows Archiv. a, Pathological Anatomy and Histopathology. 416: 491-6. PMID 2110696 DOI: 10.1007/Bf01600299  0.582
1990 Cardesa A, Ribalta T, Vogeley KT, Reifenberger G, Wechsler W, Turusov VS. Pathology of tumours in laboratory animals. Tumours of the rat. Tumours of the peripheral nervous system. Iarc Scientific Publications. 699-724. PMID 2093667  0.47
1990 Sugita Y, Kepes JJ, Shigemori M, Kuramoto S, Reifenberger G, Kiwit JC, Wechsler W. Pleomorphic xanthoastrocytoma with desmoplastic reaction: angiomatous variant. Report of two cases. Clinical Neuropathology. 9: 271-8. PMID 1962743  0.544
1989 Reifenberger G, Deckert M, Wechsler W. Immunohistochemical determination of protein kinase C expression and proliferative activity in human brain tumors. Acta Neuropathologica. 78: 166-75. PMID 2750486 DOI: 10.1007/Bf00688205  0.611
1989 Deckert M, Reifenberger G, Wechsler W. Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67. Journal of Cancer Research and Clinical Oncology. 115: 179-88. PMID 2715168 DOI: 10.1007/Bf00397921  0.621
1989 Bilzer T, Reifenberger G, Wechsler W. Chemical induction of brain tumors in rats by nitrosoureas: molecular biology and neuropathology. Neurotoxicology and Teratology. 11: 551-6. PMID 2696875 DOI: 10.1016/0892-0362(89)90036-6  0.585
1989 Reifenberger G, Prior R, Deckert M, Wechsler W. Epidermal growth factor receptor expression and growth fraction in human tumours of the nervous system. Virchows Archiv. a, Pathological Anatomy and Histopathology. 414: 147-55. PMID 2563600 DOI: 10.1007/Bf00718594  0.589
1989 Prior R, Reifenberger G, Wechsler W. Nerve growth factor receptor in tumours of the human nervous system. Immunohistochemical analysis of receptor expression and tumour growth fraction. Pathology, Research and Practice. 185: 332-8. PMID 2478988 DOI: 10.1016/S0344-0338(89)80008-1  0.567
1989 Reifenberger G, Bilzer T, Seitz RJ, Wechsler W. Expression of vimentin and glial fibrillary acidic protein in ethylnitrosourea-induced rat gliomas and glioma cell lines. Acta Neuropathologica. 78: 270-82. PMID 2475009 DOI: 10.1007/Bf00687757  0.697
1987 Szymas J, Reifenberger G, Wechsler W. Leu-M1 immunoreactivity in the human brain. Discrimination between different tumors and between neoplastic and brain tissue. Die Naturwissenschaften. 74: 188-90. PMID 3600813 DOI: 10.1007/BF00372924  0.513
1987 Reifenberger G, Szymas J, Wechsler W. Differential expression of glial- and neuronal-associated antigens in human tumors of the central and peripheral nervous system. Acta Neuropathologica. 74: 105-23. PMID 3314309 DOI: 10.1007/BF00692841  0.566
1987 Reifenberger G, Mai JK, Krajewski S, Wechsler W. Distribution of anti-Leu-7, anti-Leu-11a and anti-Leu-M1 immunoreactivity in the brain of the adult rat. Cell and Tissue Research. 248: 305-13. PMID 2438044 DOI: 10.1007/Bf00218197  0.517
Show low-probability matches.